{"id":625,"date":"2025-04-18T17:14:38","date_gmt":"2025-04-18T08:14:38","guid":{"rendered":"https:\/\/www.kchnet.or.jp\/krm\/?page_id=625"},"modified":"2025-12-01T10:53:27","modified_gmt":"2025-12-01T01:53:27","slug":"result","status":"publish","type":"page","link":"https:\/\/www.kchnet.or.jp\/krm\/about\/result\/","title":{"rendered":"\u5f53\u79d1\u306e\u5b9f\u7e3e"},"content":{"rendered":"\n
\n

\u8a3a\u7642\u5b9f\u7e3e<\/h3>\n\n\n\n
\n
\n
\n

2023\u5e74\u5ea6-2024\u5e74\u5ea6 \u5165\u9662\u60a3\u8005\u6570<\/h4>\n\n\n\n
\"2023\u5e74\u5ea6-2024\u5e74\u5ea6<\/figure>\n<\/div>\n\n\n\n
\n
<\/div><\/div>\n\n\n\n
\n

\u5358\u4f4d\uff1a\u4eba<\/p>\n\n\n\n

<\/th>2023\u5e74\u5ea6<\/th>2024\u5e74\u5ea6<\/th><\/tr><\/thead>
\u5165\u9662\u60a3\u8005\u6570<\/td>2076<\/td>2114<\/td><\/tr>
\u6551\u6025\u5916\u6765\u60a3\u8005\u6570<\/td>132<\/td>278<\/td><\/tr>
\u5165\u9662\u4e2d\u5f80\u8a3a\u60a3\u8005\u6570<\/td>522<\/td>727<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

2023\u5e74\u5ea6\u30fc2024\u5e74\u5ea6\u5404\u7a2e\u691c\u67fb\u306e\u5185\u8a33<\/h4>\n\n\n\n
\"2023\u5e74\u5ea6-2024\u5e74\u5ea6<\/figure>\n<\/div>\n\n\n\n
\n
<\/div><\/div>\n\n\n\n
\n

\u5358\u4f4d\uff1a\u4eba<\/p>\n\n\n\n

<\/th>2023\u5e74\u5ea6<\/th>2024\u5e74\u5ea6<\/th><\/tr><\/thead>
\u6c17\u7ba1\u652f\u80ba\u80de\u6d17\u6d44<\/td>217<\/td>166<\/td><\/tr>
TBLB(\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u306eTBLB\u9664\u304f)<\/td>347<\/td>348<\/td><\/tr>
\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc<\/td>85<\/td>63<\/td><\/tr>
EBUS-TBNA<\/td>85<\/td>81<\/td><\/tr>
\u5c40\u6240\u9ebb\u9154\u4e0b\u80f8\u8154\u93e1\u691c\u67fb<\/td>12<\/td>13<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

\u7814\u7a76\u6d3b\u52d5\u5b9f\u7e3e<\/h3>\n\n\n\n
\n

\u8ad6\u6587<\/h4>\n\n\n\n
\n
\n

2024\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

\n
\n
\n

\u82f1\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

\n
\n

\u539f\u8457<\/p>\n\n\n\n

    \n
  1. Kobe H, Hamao N, Niwa T, Ishida T\uff1aCryobiopsy for Secondary Pulmonary Alveolar\u3000Proteinosis. Cureus. 16(5). doi: 10.7759\/cureus.60530.2024<\/li>\n\n\n\n
  2. Hamakawa M, Fukuda Y, Yokoyama T, Ishida T\uff1aTransbronchial cryoablation as Local Treatment for Central Airway Malignant Tumor. Respiration.103\uff089\uff09,pp587-592.2024<\/li>\n\n\n\n
  3. Hamakawa M, Ishida T\uff1a\u200bUsefulness of Mepolizumab for Mucus Plugs. Internal Medicinedoi: 10.2169\/internalmedicine.3531-24.2024\u3000<\/li>\n\n\n\n
  4. Shiraishi Y, Yokoyama T, et al\uff1aComparison of platinum combination chemotherapy plus pembrolizumab\u3000versus platinum combination chemotherapy plus nivolumab-ipilimumab for\u3000treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial.. Lancet Respiratory Medicine.12\uff0811\uff09.pp877-887.2024<\/li>\n\n\n\n
  5. Morita A, Yokoyama T, et al\uff1a\u200bImpacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer.Nat Genet. 154(9). pp1607-1615.2024<\/li>\n\n\n\n
  6. Shibaki R, Yokoyma T, et al\uff1a\u200bMachine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer. The Journal for ImmunoTherapy of Cancer.12(2). e007987.2024<\/li>\n\n\n\n
  7. Ikeda S, Yokoyma T\uff1aNintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis. Annals of the American Thoracic Society. 21(4).PP.635-643.2024<\/li>\n\n\n\n
  8. Shibaki R, Yokoyma T, et al\uff1aDurvalumab with etoposide and carboplatin for patients with extensive-stage\u3000small cell lung cancer and interstitial lung disease: A multicenter, open-label\u3000prospective trial. Lung Cancer.196.107958.2024<\/li>\n\n\n\n
  9. Inukai Motokura Y, Ito A, Tao Y, Ishida T\uff1a\u200bSevere Adenovirus Infection with SARS-CoV-2 Co-infection. Internal Medicine.63(22).pp.3077-3081.2024<\/li>\n\n\n\n
  10. Ikeda S, Yokoyma T, et\uff1a\u200bNOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Molecular Oncology. 18(2).pp.305-316.2024<\/li>\n\n\n\n
  11. Kawataki M, Ito A, Koyama T, Ishida T\uff1a\u200bLobar pneumonia due to human metapneumovirus: a case report. International Journal of Infectious Diseases.146.107162.2024<\/li>\n\n\n\n
  12. Nakamura N, Yokoyma T, et al\uff1a\u200b\u200bA randomized, open-label phase II study on the preventive effect of goshajinkigan against peripheral neuropathy induced by paclitaxel-containing chemotherapy: The OLCSG2101 study protocol. Respiratory Investigation. 62(5). pp.897-900.2024<\/li>\n\n\n\n
  13. Nogami N, Ikeo S, Yokoyama T,et al\uff1a\u200bA single arm Phase I\/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424\/OLCSG1402: CARNAVAL). Japanese Journal of Clinical Oncology. 54(7).pp.805-812.2024<\/li>\n\n\n\n
  14. Kawachi H, Fukuda Y, et al \uff1a\u200bReal-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005). Clinical Lung Cancer. 25(7).pp.643-652e4.2024<\/li>\n\n\n\n
  15. Kobe H, Ito A, Nakanishi Y, Miyazaki Y, Takahashi H, Toyota Y, Amano A, Matsui K, Ishida T\uff1aDiagnostic Usefulness of Liquid Culture Medium for Mycobacterium avium-intracellulare Complex Lung Disease: A Single-Centre, Retrospective Study. Cureus. 16(6). DOI: 10.7759\/cureus.61542.2024<\/li>\n\n\n\n
  16. Ito A, Ishida T, Tachibana H, Nakanishi Y, Kawataki M, Yamazaki A, Washio Y. Identification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia. J Clin Microbiol 2024;62(4):e0166523.<\/li>\n<\/ol>\n<\/div>\n\n\n\n
    \n

    Case Reports<\/p>\n\n\n\n

      \n
    1. Hamakawa M, Ishida T\uff1a\u200bImaging in pleural amyloidosis:A diagnostic challenge. Respirology Case Reports. 2024;12. DOI:10.1002\/rcr2.1289.2024<\/li>\n\n\n\n
    2. Hamakawa M, Arita M, Tadashi I\uff1a\u200bA case of asthma revealed to be a much rarer condition. Respirology Case Reports. 2024;12. DOI:10.1002\/rcr2.1296.2024<\/li>\n\n\n\n
    3. Hamakawa M, Yamano T, Arita M,Niwa T,Ishida T\uff1a\u200bA case of allergic bronchopulmonary mycosis:3D-CT Findings led to successful multidisciplinary treatment with dupilumab and cryoprobe. Respirology Case Reports. 2024;12. doi:10.1002\/rcr2.1305.2024<\/li>\n\n\n\n
    4. Hamakawa M. Ishisa T\uff1a\u200bChest drainage, a basic but essential procedure. Respirology Case Reports.2024;12. DOI:10.1002\/rcr2.1299.2024<\/li>\n\n\n\n
    5. Hamakawa M, Ishida T\uff1aEfficacy of\u3000dupilumab as an alternative to coriticosterroids in the treatmntof exacerbations of allergic bronchopulmonary aspergillosis. Respirology Case Reports. DOI:10.1002\/rcr2.1354.2024<\/li>\n\n\n\n
    6. Hamakawa M, Ishida T\uff1aBenralizumab-resistant mucus plugs in severe asthma complicated by eosinophilic chronic rhinosinusitis. Respirology Case Reports. DOI:10.1002\/rcr2.70009.2024<\/li>\n\n\n\n
    7. Hamakawa M, Tanaka A, Tokioka F, Ishida T\uff1a\u200bFeasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia:3 case reports. Respirology Case Reports. DOI:10.1002\/rcr2.1412.2024<\/li>\n\n\n\n
    8. Hamakawa M, Arita M, Toyota Y, Ishida T\uff1a\u200bA pitfall in chest imaging. Respirology Case Reports. DOI: 10.1002\/rcr2.1326.2024<\/li>\n\n\n\n
    9. Tanaka A, Hamakawa M, Ishida T\uff1a\u200bIncreased lung field permeability in young patients. Clinical Case Reports. DOI: 10.1002\/ccr3.9289.2024<\/li>\n\n\n\n
    10. Takahashi H, Hamakawa M, Watanabe A,Ishida T\uff1aAllergic bronchopulmonary mycosis in Schizophyllum commune with positive Aspergillus-specific IgE antibodies: A case report. Respirology Case Reports.12\uff087\uff09. DOI: 10.1002\/rcr2.1433.2024<\/li>\n\n\n\n
    11. Kawataki M, Oda Y \uff1aLow attenuation areas in necrotizing soft tissue infection. Clinical Case Reports.1;12\uff083\uff09. doi: 10.1002\/ccr3.8566.2024<\/li>\n\n\n\n
    12. Yamano T, Yokoyama T, Ishida T\uff1a\u200bTepotinib-induced hand-foot skin reaction. Respirology Case Reports. 12(5). DOI: 10.1002\/rcr2.1395.2024<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
      \n
      \n

      \u548c\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

      \n
      \n

      \u539f\u8457\u30fb\u89e3\u8aac<\/p>\n\n\n\n

        \n
      1. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u6cbb\u7642\u85ac. Pocket Drugs.94\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6.pp836.2024<\/li>\n\n\n\n
      2. \u77f3\u7530\u3000\u76f4\uff1a1\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6. \u611f\u67d3\u75c7\u3000\u540c\u7a2e\u85ac\u306e\u7279\u5fb4\u3068\u4f7f\u3044\u5206\u3051\u65e5\u5e38\u8a3a\u7642\u306b\u6d3b\u304b\u3059\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3UP-TO-DATE 2024-2025.PP.18-23.2024<\/li>\n\n\n\n
      3. \u77f3\u7530\u3000\u76f4\uff1a\u611f\u67d3\u75c7\u3000\u540c\u7a2e\u85ac\u306e\u7279\u5fb4\u3068\u4f7f\u3044\u5206\u3051. \u6297\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u85ac. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd\u3000\u79c1\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b\u30002024\u5e74\u7248.pp163-164.2024<\/li>\n\n\n\n
      4. \u77f3\u7530\u3000\u76f4\uff1a\u611f\u67d3\u75c7\u3000\u540c\u7a2e\u85ac\u306e\u7279\u5fb4\u3068\u4f7f\u3044\u5206\u3051. \u200b4\u985e\u611f\u67d3\u75c7\u3000\u30ec\u30b8\u30aa\u30cd\u30e9\u75c7\uff08\u5728\u90f7\u8ecd\u4eba\u75c5\uff09. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd\u3000\u79c1\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b\u30002024\u5e74\u7248\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b\u30002024\u5e74\u7248.pp181\uff0d182.2024<\/li>\n\n\n\n
      5. \u77f3\u7530\u3000\u76f4\uff1achapter3 \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u4e88\u9632\u30fb\u6cbb\u7642. A\u3000\u6210\u4eba\uff0c\u9ad8\u9f62\u8005.\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\uff0f\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7 \u8a3a\u7642\u30ac\u30a4\u30c92024-25.pp37-46.2024<\/li>\n\n\n\n
      6. \u4f0a\u85e4 \u660e\u5e83. \u547c\u5438\u5668\u5185\u79d1\u8a3a\u7642\u306e\u639f \u9662\u5185\u80ba\u708e. \u4e2d\u5916\u533b\u5b66\u793e 2024.<\/li>\n\n\n\n
      7. \u4f0a\u85e4 \u660e\u5e83. \u6cbb\u7642\u6cd5\u306e\u518d\u6574\u7406\u3068\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u306e\u305f\u3081\u306b\u3000\u5c02\u9580\u5bb6\u306b\u3088\u308b\u79c1\u306e\u6cbb\u7642\u3000\u80ba\u708e\u7403\u83cc\u611f\u67d3\u75c7(\u89e3\u8aac). \u65e5\u672c\u533b\u4e8b\u65b0\u5831 2024;5215\u53f7:43-44.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
        \n
        \n

        2023\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

        \n
        \n
        \n

        \u82f1\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

        \n
        \n

        \u539f\u8457<\/p>\n\n\n\n

          \n
        1. Tokioka F, Okamoto H, Shiotsu A, Hashimoto T: Frequency and clinical features of radiographic head injury caused by inpatient falls: a single-centre retrospective cohort study. BMJ Open. 2023 Apr 24;13(4):e066426. doi: 10.1136\/bmjopen-2022-066426.2023.<\/li>\n\n\n\n
        2. Motokura Y, Ito A, Yokoe S, Iri O, Nishimura K, Kamiyama S, Ishida T: Pulmonary Cryptococcosis Diagnosed by a Transbronchial Lung Cryobiopsy in a Patient with Rheumatoid Arthritis. Intern Med. 2023 Feb 15;62(4):583-587. doi: 10.2169\/internalmedicine.9764-22. Epub 2022 Jul 29.2023.<\/li>\n\n\n\n
        3. Kawataki M, Watanabe K, Yokoyama T, Ishida T: IgA vasculitis as an immune-related adverse event of durvalumab: A case report. Respir Investig. 2023 Mar;61(2):205-209. doi: 10.1016\/j.resinv.2023.01.005. Epub 2023 Feb 9.2023.<\/li>\n\n\n\n
        4. Ito A, Ishida T, Nakanishi Y, Kobe H, Tokioka F: Eosinopenia is associated with adverse outcomes after COVID-19 infection: A perspective from Japan. Respirology. 2023 Jul;28(7):677-680. doi: 10.1111\/resp.14509. Epub 2023 Apr 27.2023.<\/li>\n\n\n\n
        5. Kobe H\u3001Yokoe S, Ishida T: \u200bIncidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: A case report. Thorac Cancer. 14\uff082\uff09.PP210-2103.2023.<\/li>\n\n\n\n
        6. Motokura Y, Ito A, Ishida T: Severe Legionella Pneumonia in Which Serial Testing by Ribotest(\u00ae) Legionella was Useful for the Diagnosis. Intern Med. 2023 Oct 15;62(20):2989-2993. doi: 10.2169\/internalmedicine.0766-22. Epub 2023 Mar 8.2023.<\/li>\n\n\n\n
        7. Oi I, Ito A, Ishida T, et al.: Pneumonia caused by severe acute respiratory syndrome coronavirus 2 andiInfluenza virus: a multicenter comparative study. Open Forum Infect Dis 2021 May 29;8(7):ofab282. doi: 10.1093\/ofid\/ofab282. eCollection.2023.<\/li>\n\n\n\n
        8. Kataoka K, Arita M, et all: Long-term effect of pulmonary rehabilitation in idiopathic pulmonary fibrosis: a randomised controlled trial. Thorax. 2023 Aug;78(8):784-791. doi: 10.1136\/thorax-2022-219792. Epub 2023 Apr 3.2023.<\/li>\n\n\n\n
        9. Wakuda K, Yokoyama T, et all: Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L). BMC Cancer. 2023 Sep 25;23(1):902. doi: 10.1186\/s12885-023-11417-w.2023.<\/li>\n\n\n\n
        10. Sakamoto T, Yokoyama T, et all: Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer. JAMA Netw Open. 2023 Dec 1;6(12):e2347700. doi: 10.1001\/jamanetworkopen.2023.47700. 2023.<\/li>\n\n\n\n
        11. Uemura T, Yokoyama T, et all: Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single-plex testing: WJOG13620L. Cancer Med. 2023 Dec;12(23):21097-21110. doi: 10.1002\/cam4.6668. Epub 2023 Nov 10. 2023.<\/li>\n\n\n\n
        12. Tsubata Y, Yokoyama T, et all:Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE\/NEJ037 study data. Int J Clin Oncol. 2023 Jan;28(1):69-78. doi: 10.1007\/s10147-022-02257-y. Epub 2022 Nov 10.2023.<\/li>\n\n\n\n
        13. Yamasue M, Ito A, et all: Rebound mortality rate of Legionella pneumonia in Japan. Respir Investig. 2023 Jul;61(4):487-489. doi: 10.1016\/j.resinv.2023.04.005. Epub 2023 May 18.2023.<\/li>\n\n\n\n
        14. Hata T, Kobe H, Yokoyama T, et all: Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study. J Cancer Res Clin Oncol. 2023 Jun;149(6):2475-2482. doi: 10.1007\/s00432-022-04125-8. Epub 2022 Jun 23.2023.<\/li>\n\n\n\n
        15. Tanizaki J, Yokoyama T, et all: Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy. JTO Clin Res Rep. 2023 Oct 13;4(12):100590. doi: 10.1016\/j.jtocrr.2023.100590. eCollection 2023 Dec.2023.<\/li>\n\n\n\n
        16. Ninomiya T, Yokoyama T, et all: A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-na\u00efve patients with non-small cell lung cancer harboring EGFR mutations. Lung Cancer. 2023 Oct;184:107349. doi: 10.1016\/j.lungcan.2023.107349. Epub 2023 Aug 19.2023.<\/li>\n\n\n\n
        17. Yonesaka K, Yokoyama T, et all: Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial. Clin Lung Cancer. 2023 Sep;24(6):519-527.e4. doi: 10.1016\/j.cllc.2023.05.008. Epub 2023 Jun 3.2023.<\/li>\n\n\n\n
        18. Hata T, Kobe H, Yokoyama T,et all: Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study. Thorac Cancer. 2023 Apr;14(11):1004-1011. doi: 10.1111\/1759-7714.14836. Epub 2023 Mar 3. 2023.<\/li>\n\n\n\n
        19. Sakata Y, Yokoyama T, et all: Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP). Lung Cancer. 2023 Dec;186:107426. doi: 10.1016\/j.lungcan.2023.107426. Epub 2023 Nov 19.2023.<\/li>\n\n\n\n
        20. Ikeda S, Yokoyama T, et all: NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study. Mol Oncol. 2023 Oct 21. doi: 10.1002\/1878-0261.13542. Online ahead of print.2023.<\/li>\n\n\n\n
        21. Wakuda K, Yokoyama T, et all: A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603\/WJOG 9116L). JTO Clin Res Rep. 2023 Oct 12;4(12):100587. doi: 10.1016\/j.jtocrr.2023.100587. eCollection 2023 Dec.2023.<\/li>\n\n\n\n
        22. Nishio M, Yokoyama T, et all: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1. Int J Clin Oncol. 2023 Oct;28(10):1354-1368. doi: 10.1007\/s10147-023-02390-2. Epub 2023 Aug 7.2023.<\/li>\n\n\n\n
        23. Sugawara S, Yokoyama T, et all: Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study. Int J Clin Oncol. 2023 May;28(5):724-725. doi: 10.1007\/s10147-022-02286-7.2023.<\/li>\n\n\n\n
        24. Nishio M, Yokoyama T, et all: Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1. Int J Clin Oncol. 2023 Oct;28(10):1369-1370. doi: 10.1007\/s10147-023-02408-9.2023.<\/li>\n\n\n\n
        25. Sakata Y, Yokoyama T, et all: Corrigendum to “Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT-EP)” [Lung Cancer 186 (2023) 107426]. Lung Cancer. 2023 Dec 29:107450. doi: 10.1016\/j.lungcan.2023.107450. Online ahead of print.2023.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
          \n
          \n

          \u548c\u6587\u96d1\u8a8c\u30fb\u66f8\u7c4d<\/p>\n<\/span><\/div>\n\n\n\n

          \n
          \n

          \u539f\u8457\u30fb\u89e3\u8aac<\/p>\n\n\n\n

            \n
          1. \u4f0a\u85e4\u660e\u5e83\uff1a\u3010\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u3092\u63a2\u308b\u3011\u6297\u83cc\u85ac\u306e\u5b9f\u8df5\u7684\u306a\u4f7f\u3044\u65b9\u3000\u30de\u30af\u30ed\u30e9\u30a4\u30c9\u4f75\u7528\u7642\u6cd5\u306e\u610f\u7fa9. \u547c\u5438\u5668\u5185\u79d1(1884-2887)43\u5dfb4\u53f7 PP370-375(2023.04).2023<\/li>\n\n\n\n
          2. \u77f3\u7530 \u76f4\uff1a\u3010\u6700\u65b0\u4e3b\u8981\u6587\u732e\u3068\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u307f\u308b\u3000\u547c\u5438\u5668\u5185\u79d1\u5b66\u30ec\u30d3\u30e5\u30fc\u30002024-’25\u3011(I\u7ae0)\u547c\u5438\u5668\u611f\u67d3\u75c7\u3000\u30a6\u30a4\u30eb\u30b9\u80ba\u708e(COVID-19\u3092\u9664\u304f). \u547c\u5438\u5668\u5185\u79d1\u5b66\u30ec\u30d3\u30e5\u30fc(2436-6846)2024-’25\u5dfb PP2-7(2023.11).2023<\/li>\n\n\n\n
          3. \u4f0a\u85e4\u660e\u5e83\uff1a\u3010\u975e\u56a2\u80de\u6027\u7dda\u7dad\u75c7\u6027\u306e\u6c17\u7ba1\u652f\u62e1\u5f35\u75c7\u3011\u6c17\u7ba1\u652f\u62e1\u5f35\u75c7\u306e\u91cd\u75c7\u5ea6\u5206\u985e. \u547c\u5438\u5668\u5185\u79d1(1884-2887)43\u5dfb4\u53f7 PP370-375(2023.04).2023<\/li>\n\n\n\n
          4. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u6cbb\u7642\u85ac. Pocket Drugs. 94\u3000\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6.PP820-824. \u8056\u8def\u52a0\u56fd\u969b\u75c5\u9662\u9662\u9577\u3000\u798f\u4e95\u6b21\u77e2. \u533b\u5b66\u66f8\u9662.2023<\/li>\n\n\n\n
          5. \u77f3\u7530\u3000\u76f4\uff1a\u200b\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068\u65b0\u578b\u30b3\u30ed\u30ca\u540c\u6642\u6d41\u884c\u306b\u5099\u3048\u308b. \u304d\u3087\u3046\u306e\u5065\u5eb7. 2023\u5e741\u6708\u53f7.PP54-57.2023<\/li>\n\n\n\n
          6. \u77f3\u7530\u3000\u76f4\uff1a\u6210\u4eba\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u4e88\u9632\u30fb\u6cbb\u7642. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u30ac\u30a4\u30c92023-24.PP58-65.2023.<\/li>\n\n\n\n
          7. \u77f3\u7530\u3000\u76f4\uff1a\u7279\u96c6\uff0f\u6700\u65b0\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u2500COVID\u221219\u3092\u898b\u636e\u3048\u3066\u2500 \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u5408\u4f75\u75c7\u306e\u6cbb\u7642. \u81e8\u5e8a\u3068\u7814\u7a76. 100(12).PP28-31.2023.<\/li>\n\n\n\n
          8. \u77f3\u7530\u3000\u76f4\uff1a\u200b\u30af\u30e9\u30df\u30b8\u30a2\u30fb\u30cb\u30e5\u30fc\u30e2\u30cb\u30a8\u80ba\u708e. \u547c\u5438\u5668\u75be\u60a3\u6700\u65b0\u306e\u6cbb\u7642\u30002023-2024. \u2164\u3000\u547c\u5438\u5668\u611f\u67d3\u75c7.PP225-227. \u5f26\u9593\u662d\u5f66\/\u897f\u5ca1\u5b89\u5f66\/\u77e2\u5bfa\u548c\u535a.\u5357\u6c5f\u5802.2023<\/li>\n\n\n\n
          9. \u77f3\u7530\u3000\u76f4\uff1a\u200b\u2161\u3000\u80ba\u708e. \u308f\u304b\u308a\u3084\u3059\u3044\u5185\u79d1\u5b66. \u7b2c1\u7ae0\u3000\u547c\u5438\u5668\u75be\u60a3\uff0d2\uff0e\u547c\u5438\u5668\u611f\u67d3\u75c7.PP11-16. \u4e95\u6751\u88d5\u592b. \u6587\u5149\u58022023.<\/li>\n\n\n\n
          10. \u77f3\u7530\u3000\u76f4\uff1a\u200b\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306b\u5bfe\u3059\u308b\u533b\u85ac\u54c1\u306e\u6700\u524d\u7dda. \u516c\u8846\u885b\u751f. 87(2).PP123-129. \u533b\u5b66\u66f8\u9662.2023.<\/li>\n\n\n\n
          11. \u77f3\u7530\u3000\u76f4\uff1a\u6297\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u85ac. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd\u3000\u79c1\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b2023\u5e74\u7248. 3\u3000\u611f\u67d3\u75c7.PP168-169. \u798f\u4e95\u6b21\u77e2\u3001\u9ad8\u6728\u8aa0\u3001\u5c0f\u5ba4\u4e00\u6210. 2023.<\/li>\n\n\n\n
          12. \u77f3\u7530\u3000\u76f4\uff1a\u200bCOVID-19. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd\u3000\u79c1\u306f\u3053\u3046\u6cbb\u7642\u3057\u3066\u3044\u308b2023\u5e74\u7248. 3\u3000\u611f\u67d3\u75c7.PP198-200 \u798f\u4e95\u6b21\u77e2\u3001\u9ad8\u6728\u8aa0\u3001\u5c0f\u5ba4\u4e00\u6210. 2023.<\/li>\n\n\n\n
          13. \u77f3\u7530\u3000\u76f4\uff1a\u200b1.\u30a6\u30a4\u30eb\u30b9\u6027\u80ba\u708e\uff08COVID-19\u3092\u9664\u304f\uff09. \u547c\u5438\u5668\u5185\u79d1\u5b66\u30ec\u30d3\u30e5\u30fc\u30002024-25. \u2160\u7ae0\u3000\u547c\u5438\u5668\u611f\u67d3\u75c7.PP2-7. \u5f26\u9593\u662d\u5f66. \u7dcf\u5408\u533b\u5b66\u793e.2023.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
            \n
            \n

            2022\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

            \n
            \n
            \n

            \u82f1\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

            \n
            \n

            \u539f\u8457<\/p>\n\n\n\n

              \n
            1. Takazono T, Ishida T, Tokioka F\uff0cMukae H, et al.: Empirical antibiotic usage and bacterial superinfections in patients with COVID-19 in Japan: A nationwide survey by the Japanese Respiratory Society. Respir Invest<\/em> 60(1); 154-157, 2022.<\/li>\n\n\n\n
            2. Ito A, Ishida T, Nakanishi Y, Yamazaki A, Washio Y: Inflammatory biomarkers are not useful for predicting prognosis in nursing and healthcare-associated pneumonia: a prospective, cohort study. J Infect Chemother <\/em>28(5); 623-30, 2022.<\/li>\n\n\n\n
            3. Nagata K, Horie T, Chohnabayash N, Jinta T, Tokioka F, Ishida T, et al.\uff1a\u200bHome high flow nasal cannula oxygen therapy for stable hypercapnic COPD: a randomized clinical trial\uff0eAm J Respir Critl Care Med<\/em> 206(11); 1326-35, 2022.<\/li>\n\n\n\n
            4. Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota J, et al.: \u200bClinical manifestations of hospitalized influenza patients without risk factors: a prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother <\/em>28(7); 853-8, 2022.<\/li>\n\n\n\n
            5. Kobe H, Ito A, Nakanishi Y, Kuriyama A, Tachibana H, Ishida T: Addition of baricitinib to COVID-19 treatment does notincrease bacterial infection compared to standard therapy: a single-center retrospective study. Intern Med <\/em>61(15); 2273-9, 2022.<\/li>\n\n\n\n
            6. Sato Y, Sumikawa H, Shibaki R, Morimoto T, Sakata Y, Oya Y, Tamiya M, Suzuki H, Matsumoto H, Yokoi T, Hashimoto K, Kobe H, et al.: Drug-related pneumonitis induced by osimertinib as first-line treatment for epidermal growth factor receptor mutation-positive non-small cell lung cancer: a real-world setting. Chest<\/em> 162(5); 1188-98, 2022.<\/li>\n\n\n\n
            7. Hayashi H, Sugawara S, Fukuda Y, Fujimoto D, Miura S, Ota K, et al.: A randomized phase II study comparing nivolumab with carboplatin-pemetrexed for EGFR-mutated NSCLC with resistance to EGFR tyrosine kinase inhibitors (WJOG8515L). Clin Cancer Res<\/em> 28(5); 893-902, 2022.<\/li>\n\n\n\n
            8. Hayashi H, Yonesaka K, Nakamura A, Fujimoto D, Azuma K, Sakata S, Tachihara M, Ikeda S, Yokoyama T, et al.: Alternating therapy with osimertinib and afatinib for treatment-naive patients with EGFR-mutated advanced non-small cell lung cancer: A single-group, open-label phase 2 trial (WJOG10818L). Lung Cancer<\/em> 168(6): 38-45, 2022.<\/li>\n\n\n\n
            9. Kobe H, Momose M, Miyazaki Y, Nishihara C, Yoshida T, Ishida T: A 73-year-old man with refractory hemoptysis. Chest<\/em> 162(4): e165-8, 2022.<\/li>\n\n\n\n
            10. Imamura Y, Miyazaki T, Watanabe A, Tsukada H, Nagai H, Hasegawa Y, Tomono K,Ito I,Teramoto S, Ishida T, et al.: Prospective multicenter survey for nursing and healthcare-associated pneumonia in Japan. J Infect Chemothe<\/em>r 28(8); 1125-30, 2022.<\/li>\n\n\n\n
            11. Fujimoto D, Akamatsu H, Morimoto T, Wakuda K, Sato Y, Kawa Y, Yokoyama T, et al.: Histologic transformation of epidermal growth factor receptor-mutated lung cancer. Eur J Cancer<\/em> 66(5): 41-50, 2022.<\/li>\n\n\n\n
            12. Kinjo T, Ito A, Ishii M, Komiya K, Yamasue M, Yamaguchi T, et al.: National survey of physicians in Japan regarding their use of diagnostic tests for legionellosis. J Infect Chemother<\/em> 28(2); 129-34, 2022.<\/li>\n\n\n\n
            13. Tamiya M, Fujikawa K, Suzuki H, Yokoyama T, Uenami T, Tamiya A, Sato Y, Saito G, Uchida J, Morita M, Hirashima T, Fukuda Y, et al.: Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002. Invest New Drugs<\/em> 40(2); 361-369, 2022.<\/li>\n\n\n\n
            14. Kanemura H, Hayashi H, Tomida S, Tanizaki J, Suzuki S, Kawanaka Y, Tsuya A, Fukuda Y, et al.: The tumor immune microenvironment and frameshift neoantigen load determine response to PD-L1 blockade in extensive-stage SCLC. JTO Clin Res Rep<\/em> 3(8); 100373,  2022.<\/li>\n\n\n\n
            15. Ito A, Shime N, Fujishima S, Fujitani S, Komiya K, Schuetz P. An algorithm for PCT-guided antimicrobial therapy: a consensus statement by Japanese experts. Clin Chem Lab 2022;61(3):407-411.<\/li>\n<\/ol>\n<\/div>\n\n\n\n
              \n

              Case Reports<\/p>\n\n\n\n

                \n
              1. Kawataki M, Nakanishi Y, Yokoyama T, Ishida T: Hypothyroidism as an immune-related adverse event caused by atezolizumab in a patient with muscle spasms: a case report. Respir Med Case Reports <\/em>101585(2022), 36, 2022.<\/li>\n\n\n\n
              2. Kobe H\uff0cYokoe S, Ishida T\uff1a\u200bIncidental diagnosis of pulmonary cryptococcosis by rebiopsy for epidermal growth factor receptor T790M mutation: a case report. Thoracic Cancer<\/em> doi: 10.1111\/1759-7714.14753.2022<\/li>\n\n\n\n
              3. Kawataki M, Nakanishi Y, Niwa T, Ishida T: Air embolism after transbronchial lung cryobiopsy: a case report. Respirol Case Rep<\/em> 10(10): e01038, 2022.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                \n
                \n

                \u548c\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

                \n
                \n

                \u539f\u8457\u30fb\u89e3\u8aac<\/p>\n\n\n\n

                  \n
                1. \u672c\u5009\u512a\u7f8e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u4e2d\u897f\u967d\u7950\u3001\u798f\u7530 \u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e39\u7fbd\u3000\u5d07\u3001\u767e\u702c\u3000\u5321\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067\u8a3a\u65ad\u306b\u81f3\u3063\u305f, \u518d\u71c3\u3057\u305f\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\u306e1\u4f8b. \u6c17\u7ba1\u652f\u5b66. 44(1).13-19.2022<\/li>\n\n\n\n
                2. \u77f3\u7530\u3000\u76f4\uff1a\u30a6\u30a4\u30eb\u30b9\u3092\u77e5\u308b\u3000\u8a71\u984c\u306e\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7.\u6210\u4eba\u306e\u547c\u5438\u5668\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\uff5e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3092\u4e2d\u5fc3\u306b\uff5e. \u30e1\u30c7\u30a3\u30b3\u30d4\u30a2. 63.132-155.2022<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                  \n
                  \n

                  \u5358\u884c\u672c<\/p>\n<\/span><\/div>\n\n\n\n

                  \n
                    \n
                  1. \u4f0a\u85e4\u660e\u5e83\uff1a\u91cd\u75c7\u5ea6\u5206\u985e.\u6c17\u7ba1\u652f\u62e1\u5f35\u75c7Up to Date. 6;123-27, 2022.<\/li>\n\n\n\n
                  2. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6. \u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3UP-TO-DATE\u30002022-2023. \u2160.\u611f\u67d3\u75c7.24-9, 2022.<\/li>\n\n\n\n
                  3. \u77f3\u7530\u3000\u76f4\uff1a3.\u5e02\u4e2d\u80ba\u708e. \u611f\u67d3\u75c7\u6700\u65b0\u306e\u6cbb\u7642\u30002022-2024. 122-4, 2022.<\/li>\n\n\n\n
                  4. \u77f3\u7530\u3000\u76f4\uff1a15.\u30bf\u30df\u30d5\u30eb\uff5e\u6700\u3082\u30a8\u30d3\u30c7\u30f3\u30b9\u306e\u3042\u308b\u6297\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u85ac\uff5e\uff08\u30aa\u30bb\u30eb\u30bf\u30df\u30d3\u30eb\u30ea\u30f3\u9178\u5869\uff09. \u306a\u3093\u3067\u4f7f\u3046\u306e\uff1f\u305d\u306e\u304f\u3059\u308a\u3000\u533b\u5e2b\u304c\u8003\u3048\u308b\u304f\u3059\u308a\u306e\u7acb\u3061\u4f4d\u7f6e. 50-3, 2022.<\/li>\n\n\n\n
                  5. \u77f3\u7530\u3000\u76f4\uff1a\u200b1.\u30a6\u30a4\u30eb\u30b9\u80ba\u708e\uff08COVID-19\u3092\u9664\u304f\uff09. \u6700\u65b0\u4e3b\u8981\u6587\u732e\u3068\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u307f\u308b\u3000\u547c\u5438\u5668\u5185\u79d1\u5b66\u30ec\u30d3\u30e5\u30fc\u30002022-23. 2-8, 2022.<\/li>\n\n\n\n
                  6. \u77f3\u7530\u3000\u76f4\uff1a5\u985e\u611f\u67d3\u75c7-\u5b9a\u70b9\u628a\u63e1\u3000\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u611f\u67d3\u75c7. \u4eca\u65e5\u306e\u6cbb\u7642\u6307\u91dd\u30002022\u5e74\u7248. 218-9, 2022.<\/li>\n\n\n\n
                  7. \u77f3\u7530\u3000\u76f4\uff1a\u200bA \u6210\u4eba\u30fb\u9ad8\u9f62\u8005\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u4e88\u9632\u30fb\u6cbb\u7642. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\uff0f\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u8a3a\u7642\u30ac\u30a4\u30c92022-23. 116-29, 2022.<\/li>\n\n\n\n
                  8. \u77f3\u7530\u3000\u76f4\uff1a\u200b\u533b\u7642\u30fb\u4ecb\u8b77\u95a2\u9023\u80ba\u708e. \u6700\u65b0\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306b\u57fa\u3065\u304f \u547c\u5438\u5668\u75be\u60a3 \u8a3a\u7642\u6307\u91dd 2023-24. 91-6, 2022.<\/li>\n\n\n\n
                  9. \u6a2a\u5c71\u4fca\u79c0\uff1a\u9650\u5c40\u578b\u30fbPS\u4e0d\u826f. \u80ba\u764c\u85ac\u7269\u7642\u6cd5\u30ec\u30b8\u30e1\u30f3\u3000Expert\u2019s Choice. 15-6, 2022.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                    \n
                    \n

                    2021\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                    \n
                    \n
                    \n

                    \u82f1\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

                    \n
                    \n

                    \u539f\u8457<\/p>\n\n\n\n

                      \n
                    1. Ito A, Ishida T, Tachibana H, Nakanishi Y, Yamazaki A, Washio Y\uff1a Time Trend of the Sensitivity of the Pneumococcal Urinary Antigen Test for Diagnosing Pneumococcal Community-Acquired Pneumonia: An Analysis of 15-Year, Prospective Cohort Data\uff0eInfectious Diseases and Therapy10(4)\uff0e2309-2322\uff0e2021\uff0e<\/li>\n\n\n\n
                    2. Ito A, Ishida T, Tachibana H, Nakanishi Y, Yamazaki A, Washio Y:Predictors and usefulness of targeted therapy for pneumococcal community-acquired pneumonia diagnosed by the urinary antigen test: a prospective, observational cohort study\uff0eDiagnostic Microbiology and Infectious Disease10(1).doi:10.1016\/j.diagmicrobio.2021.115457.2021.<\/li>\n\n\n\n
                    3. Yamagata A, Arita M, Tachibana H, Tokioka F, Sugimoto C, Sumikawa H, Tanaka T, Yasui H, Fujisawa T, Nakamura Y, Suda T, Ishida T: Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respiratory Research.22\uff081\uff09. doi:10.1186\/s12931-021-01726-8.2021.<\/li>\n\n\n\n
                    4. Kobe H, Arita M, Maeda T, Nagata O, Niwa T, Tokioka F\u3001Ishisa T\uff1aAcute Pulmonary Graft-Versus-Host Disease in a Patient with Adult T-cell Leukemia-Lymphoma Diagnosed by a Cryobiopsy. Internal Medicine. doi:10.2169\/internalmedicine.6358-20.2021.<\/li>\n\n\n\n
                    5. Ito A, Ishida T, Tachibana H, Nakanishi Y, Tokioka F, Yamazaki A, Washio Y,\u3001Irie H, Otake T\uff1aUsefulness of \u03b2-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study. J Infect Chemother. 2021 Oct;27(10):1447-1453. doi: 10.1016\/j.jiac.2021.06.003.2021.<\/li>\n\n\n\n
                    6. Mitsui M, Ito A, Ishida T, Tachibana H, Nakanishi Y, Yamazaki A, Washio Y\uff1aIncreased risk of Legionella pneumonia as community-acquired pneumonia after heavy rainfall in 2018 in west Japan. J Infect Chemother. 2021.Oct;27(10):1429-1435. doi: 10.1016\/j.jiac.2021.05.018.2021.<\/li>\n\n\n\n
                    7. Yamagata A, Yokoyama T, Fukuda Y, Ishida T\uff1aImpact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer. Cancer Chemother Pharmacol. 87(2):251-258. doi: 10.1007\/s00280-020-04205-x.2021.<\/li>\n\n\n\n
                    8. Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota JI, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A\uff1aClinical anifestations of adult patients requiring influenza-associated hospitalization\uff1aA prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother. 27(3):480-485. doi.org\/10.1016\/j.jiac.2020.10.021.2021.<\/li>\n\n\n\n
                    9. Kobe H, Ito A, Hayata H, Nishimura K, Ueda Y, Ishida T\uff1aMycophenolate Mofetil-induced Diffuse Large B-cell Lymphoma in Which a Solitary Lung Nodule Remitted Spontaneously.
                      Intern Med. 2021 Jan 1;60(1):131-136. doi: 10.2169\/internalmedicine.5027-20.2021.<\/li>\n\n\n\n
                    10. Ito A, Yamamoto Y, Ishii Y, Okazaki A, Ishiura Y, Kawagishi Y, Takiguchi Y, Kishi K, Taguchi Y, Shinzato T, Okochi Y, Hayashi R, Nakamori Y, Kichikawa Y, Murata K, Takeda H, Higa F, Miyara T, Saito K, Ishikawa T, Ishida T, Tateda K: Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia. Int J Infect Dis. 2021 Feb;103:42-47. doi:10.1016\/j.ijid.2020.10.106.2021.<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                      \n

                      Case Report<\/p>\n\n\n\n

                        \n
                      1. Yamagata A, Yokoyama T, Fukuda Y, Ishida T: Alectinib re-challenge in small cell lung cancer transformation after chemotherapy failure in a patient with ALK-positive lung cancer: A case report. Respiratory Medicine Case Reports.33. dio:10.1016\/j.rmcr.2021.101440.2021.<\/li>\n\n\n\n
                      2. Kawataki M, Ito A, Ishida T: Pneumonia Due to Human Coronavirus OC43 in an Immunocompetent Adult Detected by Multiplex Polymerase Chain Reaction. Internal Medicine. 60(21).3497\uff0d3501.2021.<\/li>\n\n\n\n
                      3. Kobe H, Arita M, Kadoba K, Niwa T, Tokika F, Ishida T\uff1aAcute onset systemic Iupus erythematosus interstitial lung disease\uff1aA case report. Respiratory Medicine Case Reports. 32(2021). doi.org\/10.1016\/j.rmcr.2020.101.329.2021.<\/li>\n\n\n\n
                      4. Kobe H, Ito A, Ishida T\uff1aCOVID-19-induced adult multisystem inflammatory syndrome and fatal acute limb ischaemia.Respirology Case reports.doi.org\/10.1002\/rcr2.886.2021.<\/li>\n\n\n\n
                      5. Kobe H, Saito K, Arita M, Ishida T\uff1aCryobiopsy for Pneumocystis jirovecii pneumonia secondary to adult T-cell lymphoma\/leukaemia. Respirology Case Rep. 2021 Dec 21;10(1):e0893. doi: 10.1002\/rcr2.893.2021.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                        \n
                        \n

                        \u548c\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

                        \n
                        \n

                        \u539f\u8457\u30fb\u89e3\u8aac<\/p>\n\n\n\n

                          \n
                        1. \u77f3\u7530\u3000\u76f4: \u305d\u306e\u54b3\u3063\u3066\u306a\u3042\u306b\uff1f. \u611f\u67d3\u3068\u6d88\u6bd2. 28(1). \u5165\u9580\u8b1b\u5ea7\/\u5fae\u751f\u7269\u306e\u57fa\u790e\u77e5\u8b58.pp21-25.2021.<\/li>\n\n\n\n
                        2. \u77f3\u7530\u3000\u76f4: \u30ec\u30b8\u30aa\u30cd\u30e9\u75c7. \u691c\u67fb\u3068\u6280\u8853. 49(6). \u75be\u60a3\u3068\u691c\u67fb\u5024\u306e\u63a8\u79fb.pp694-699.2021.<\/li>\n\n\n\n
                        3. \u77f3\u7530\u3000\u76f4: \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u306e\u6700\u524d\u7dda. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u96d1\u8a8c. 110(9).pp1965-1971.2021<\/li>\n\n\n\n
                        4. \u4f0a\u85e4\u3000\u660e\u5e83, \u77f3\u7530\u3000\u76f4\uff1a \u5b63\u7bc0\u6027\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6. \u611f\u67d3\u3068\u6297\u83cc\u85ac. 24(3). \u30dd\u30b9\u30c8\u30b3\u30ed\u30ca\u306b\u5099\u3048\u308b\u3079\u304d\u65e5\u5e38\u611f\u67d3\u75c7\u2015\u52d5\u5411\u30fb\u5bfe\u7b56\u30fb\u6cbb\u7642\u306e\u57fa\u672c\u307e\u3067.\uff50\uff50151\uff0d158.2021.<\/li>\n\n\n\n
                        5. \u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u3010\u3042\u306a\u305f\u306e\u300c\u77e5\u308a\u305f\u304b\u3063\u305f!\u300d\u306b\u7b54\u3048\u307e\u3059!\u3000\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u5bfe\u7b56Q&A68\u3011(\u7b2c2\u7ae0)\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u57fa\u790e\u77e5\u8b58\u3000ECMO(VV ECMO)\u88c5\u7740\u6642\u306e\u60a3\u8005\u306e\u6ce8\u610f\u70b9\u306f\u4f55\u3067\u3059\u304b?(VV ECMO\u3092\u4e2d\u5fc3\u306b). INFECTION CONTROL(0919-1011)2021\u6625\u5b63\u5897\u520a Page51-56.2021.<\/li>\n\n\n\n
                        6. \u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u3010\u3042\u306a\u305f\u306e\u300c\u77e5\u308a\u305f\u304b\u3063\u305f!\u300d\u306b\u7b54\u3048\u307e\u3059!\u3000\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u5bfe\u7b56Q&A68\u3011(\u7b2c2\u7ae0)\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u57fa\u790e\u77e5\u8b58\u3000\u4eba\u5de5\u547c\u5438\u5668\u88c5\u7740\u6642\u306e\u60a3\u8005\u306e\u6ce8\u610f\u70b9\u306f\u4f55\u3067\u3059\u304b?. INFECTION CONTROL(0919-1011)2021\u6625\u5b63\u5897\u520a Page46-50(2021.02).2021<\/li>\n\n\n\n
                        7. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\uff1a\u547c\u5438\u5668\u611f\u67d3\u75c7\u6cbb\u7642\u306b\u304a\u3051\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u306e\u610f\u7fa9. \u547c\u5438\u5668\u5185\u79d1(1884-2887)39\u5dfb6\u53f7 Page549-554.2021<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                          \n
                          \n

                          \u5358\u884c\u672c<\/p>\n<\/span><\/div>\n\n\n\n

                          \n
                            \n
                          1. \u77f3\u7530\u3000\u76f4\uff1a4\u9662\u5185\u80ba\u708e\uff08\u65e5\u548c\u898b\u80ba\u708e\u3092\u542b\u3080\uff09. \u547c\u5438\u5668\u75c5\u30ec\u30b8\u30c7\u30f3\u30c8\u30de\u30cb\u30e5\u30a2\u30eb\u7b2c6\u7248. \u7b2c3\u7ae0\u4e3b\u306a\u547c\u5438\u5668\u75be\u60a3\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\uff0f\uff21.\u80ba\u611f\u67d3\u75c7.\uff50\uff50214\uff0d218.2021.<\/li>\n\n\n\n
                          2. \u4f0a\u85e4\u3000\u660e\u5e83\uff1a1\u304b\u305c\u75c7\u5019\u7fa4\uff65\u4e0a\u6c17\u9053\u708e\uff0c\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6. \u547c\u5438\u5668\u75c5\u30ec\u30b8\u30c7\u30f3\u30c8\u30de\u30cb\u30e5\u30a2\u30eb\u7b2c6\u7248. \u7b2c3\u7ae0\u4e3b\u306a\u547c\u5438\u5668\u75be\u60a3\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\uff0f\uff21.\u80ba\u611f\u67d3\u75c7.\uff50\uff50186\uff0d195.2021.<\/li>\n\n\n\n
                          3. \u6a2a\u5c71\u3000\u4fca\u79c0\uff1a5\u7e26\u9694\u816b\u760d. \u547c\u5438\u5668\u75c5\u30ec\u30b8\u30c7\u30f3\u30c8\u30de\u30cb\u30e5\u30a2\u30eb\u7b2c6\u7248. \u7b2c3\u7ae0\u4e3b\u306a\u547c\u5438\u5668\u75be\u60a3\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\uff0fC.\u80ba\u816b\u760d.\uff50\uff50339\uff0d342.2021.<\/li>\n\n\n\n
                          4. \u77f3\u7530\u3000\u76f4\uff1a8\u5e02\u4e2d\u80ba\u708e. \u898b\u308b\u8a3a\u308b\u308f\u304b\u308b\uff01\u3000\u80f8\u90e8\u753b\u50cf\u8a3a\u65ad.\uff50\uff5051\uff0d55.2021.<\/li>\n\n\n\n
                          5. \u77f3\u7530\u3000\u76f4\uff1a15\u85ac\u5264\u6027\u80ba\u708e\uff083\uff09. \u898b\u308b\u8a3a\u308b\u308f\u304b\u308b\uff01\u3000\u80f8\u90e8\u753b\u50cf\u8a3a\u65ad.\uff50\uff5092\uff0d95.2021<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                            \n
                            \n

                            2020\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                            \n
                            \n
                            \n

                            \u82f1\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

                            \n
                            \n

                            \u539f\u8457<\/p>\n\n\n\n

                              \n
                            1. Ito A, Ishida T, et all\uff1aThe utility of serial procalcitonin measurements in addition to pneumonia severity cores in hospitalised community-acquired pneumonia. A multicentre, prospective study. International Journal of Infectious Diseases. 228-233.2020.<\/li>\n\n\n\n
                            2. Ito A, Tokumasu H, Yamasaki A, Washio Y, Ishida T: Evaluation of pneumonia severity scoring systems in nursing and healthcare-associated pneumonia for predicting prognosis: A prospective, cohort study : Journal of Infection and Chemotherapy,26(2020), 372-378.2020.<\/li>\n\n\n\n
                            3. Ishida T: Antimicrobial Selection for aspiration Pneumonia: What Is the Important Point of Antimicrobial Selection for Aspiration Pneumonia?: Aspiration Pneumonia.75-83.2020.<\/li>\n\n\n\n
                            4. Ishida T: Treatment Guidelines for Influenza Virus Infection: What Does the Recent Guideline State?: Influenza. Part \u2164 Management,pp129-136.2020.<\/li>\n\n\n\n
                            5. Ishida T, Seki M, Oishi K, Takeda K, Fujita J, et al: Clinical manifestations of adult patients requiring influenza-associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillance. Journal of Infection and Chemotherapy. doi:org\/10.1016\/j.jiac.2020.10.021.2020.<\/li>\n\n\n\n
                            6. Yamagata \uff21, Yokoyama T, Fukuda Y, Ishida T: Impact of interstitial lung disease associated with immune checkpoint inhibitors on prognosis in patients with non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. doi:org\/10.1007\/s00280-020-0425-x.2020.<\/li>\n\n\n\n
                            7. Kobe H, Ito A, Hayata H, Nishimura K, Ueda Y, Ishida T: A case of Mycophenolate Mofetil-induced Diffuse Large B-cell Lymphoma in Which a Solitary Lung Nodule Remitted Spontaneously. Internal Medicine. doi:10.2169\/internalmedicine.5027-20.2020<\/li>\n\n\n\n
                            8. Yamagata A, Arita M, Tanaka A,Tokioka F, Yoshida T, Nisimura K: Therapeutic plasma exchange for clinically amyopathic dermatomyositis(CADM)associated with rapidly progressive interstitial pneumonia. Wiley\u3000Online Library. doi:10.1002\/jca.21824.2020.<\/li>\n\n\n\n
                            9. Kobe H, Arita M, Niwa T, Tokioka F, Ishida T: Acute onset systemic lupus erythematosus interstitial lung disease: A case report. Respiratory Medicine Case Reports. doi.org\/10.1016\/j.rmcr.2020.101329.2020.<\/li>\n\n\n\n
                            10. Yamagata A, Ito A, Nakanishi Y, Ishida T: Prognostic factors in nursing and healthcareassociated pneumonia. Journal of Infection and Chemotherapy. 26(2020):563-569.2020.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                              \n
                              \n

                              \u548c\u6587\u96d1\u8a8c<\/p>\n<\/span><\/div>\n\n\n\n

                              \n
                              \n

                              \u539f\u8457\u30fb\u89e3\u8aac<\/p>\n\n\n\n

                                \n
                              1. \u77f3\u7530 \u76f4\uff1a\u305d\u306e\u54b3\u55fd\u3068\u5598\u9cf4\u3001\u5598\u606f\u3067\u3059\u304b\uff1f. \u9031\u520a\u65e5\u672c\u533b\u4e8b\u65b0\u5831.5001. \u30d7\u30e9\u30bf\u30ca\u30b9\uff5e\u79c1\u306e\u30ab\u30eb\u30c6\u304b\u3089\uff5e.pp3.2020.<\/li>\n\n\n\n
                              2. \u4f0a\u85e4 \u660e\u5e83\uff1a\u80ba\u708e\u7403\u83cc\u611f\u67d3\u75c7\/\u30ec\u30b8\u30aa\u30cd\u30e9\u611f\u67d3\u75c7. \u6551\u6025\u30fb\u96c6\u4e2d\u6cbb\u764231\uff084\uff09. ICU\u6cbb\u7642\u65b9\u91dd\u2162.pp1726-1735.2020.<\/li>\n\n\n\n
                              3. \u77f3\u7530 \u76f4\uff1a\u8aa4\u56a5\u6027\u80ba\u708e\u306e\u4e88\u9632\u3068\u6cbb\u7642. \u65e5\u672c\u81e8\u7240. 78\uff084\uff09\u3001\u901a\u5dfb\u7b2c1175\u53f7. \u7279\u96c6\uff1a\u9ad8\u9f62\u8005\u306e\u80ba\u708e\u2164.\u6cbb\u7642.pp 651-657. 2020.<\/li>\n\n\n\n
                              4. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u6cbb\u7642\u85ac. Pocket Drugs2020. 94\u3000\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6.\uff50\uff50754-758.2020.\u3000<\/li>\n\n\n\n
                              5. \u77f3\u7530 \u76f4\uff1a\u6210\u4eba\u30fb\u9ad8\u9f62\u8005\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u30ac\u30a4\u30c9. 2020-21. 3.\u4e88\u9632\u30fb\u6cbb\u7642.PP81.2020.\u3000<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                \n
                                \n

                                \u5358\u884c\u672c<\/p>\n<\/span><\/div>\n\n\n\n

                                \n
                                  \n
                                1. \u77f3\u7530 \u76f4\uff1a\u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u80ba\u708e. \u65b0\u81e8\u5e8a\u5185\u79d1\u5b66. \u7b2c11\u7ae0 \u611f\u67d3\u75c7\u75be\u60a3 1 \u30de\u30a4\u30b3\u30e9\u30ba\u30de\u611f\u67d3\u75c7.1594-1596.2020.<\/li>\n\n\n\n
                                2. \u77f3\u7530 \u76f4\uff1a\u30af\u30e9\u30df\u30b8\u30a2\u80ba\u708e\u3001\u30aa\u30a6\u30e0\u75c5. \u65b0\u81e8\u5e8a\u5185\u79d1\u5b66. \u7b2c11\u7ae0 \u611f\u67d3\u75c7\u75be\u60a3  2 \u30af\u30e9\u30df\u30b8\u30a2\u611f\u67d3\u75c7.1596-1597.2020.<\/li>\n\n\n\n
                                3. \u77f3\u7530 \u76f4\uff1a\u30aa\u30a6\u30e0\u75c5. \u4eca\u65e5\u306e\u8a3a\u65ad\u6307\u91dd\u7b2c8\u7248. 12.\u611f\u67d3\u6027\u75be\u60a3.1319-1321.2020.<\/li>\n\n\n\n
                                4. \u77f3\u7530 \u76f4\uff1a\u533b\u7642\u30fb\u4ecb\u8b77\u95a2\u9023\u80ba\u708e. \u4eca\u65e5\u306e\u8a3a\u65ad\u6307\u91dd\u7b2c8\u7248. 5.\u547c\u5438\u5668\u75be\u60a3.944-945.2020.<\/li>\n\n\n\n
                                5. \u77f3\u7530 \u76f4\uff1a\u304b\u305c\u75c7\u5019\u7fa4\u3001\u4e0a\u6c17\u9053\u708e\/\u6025\u6027\u6c17\u7ba1\u652f\u708e\u3001\u6025\u6027\u7d30\u6c17\u7ba1\u652f\u708e\/\u6162\u6027\u4e0b\u6c17\u9053\u611f\u67d3\u75c7\/\u7d30\u83cc\u6027\u80ba\u708e\u3001\u80ba\u5316\u81bf\u75c7,\u81bf\u80f8\uff1a\u5185\u79d1\u5b66\u66f8. 6.\u547c\u5438\u5668\u611f\u67d3\u75c7\u304a\u3088\u3073\u708e\u75c7\u6027\u75be\u60a3. Vol.2.PP440-445.2020.<\/li>\n\n\n\n
                                6. \u77f3\u7530 \u76f4\uff1a\u30a6\u30a4\u30eb\u30b9\u6027\u80ba\u708e. \u5185\u79d1\u5b66\u66f8. 6.\u547c\u5438\u5668\u611f\u67d3\u75c7\u304a\u3088\u3073\u708e\u75c7\u6027\u75be\u60a3. Vol2.PP448-450.2020.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                  \n

                                  \u5b66\u4f1a\u767a\u8868<\/h4>\n\n\n\n
                                  \n
                                  \n

                                  2024\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                  \n
                                  \n
                                  \n

                                  \u56fd\u969b\u5b66\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                  \n
                                    \n
                                  1. Takahash T, Arita M, Tachibana H, Ishida T\uff1aRisk of recurrent anti-aminoacyl-tRNA-synthetase antibody-associated interstitial lung disease due to anti-Ro52 antibodies.ERS Congress 2024.2024.9.7\uff0d11.Wien<\/li>\n\n\n\n
                                  2. Matsui K, Hamakawa M, Ishida T\uff1aVexas syndrome with some patterns of pulmonary shadows. Asian Pacific Society of Respirology2024.2024.11.7-10.Hong Kong<\/li>\n\n\n\n
                                  3. Hamakawa M, Niwa T, Fukuda Y, Yokoyama T, Ishida Y\uff1aEfficacy and safety of flexible bronchoscopic cryoablation for central airway malignant tumor. The 23rd World Congress for Bronchology and Interventional Pulmonology.2024.10.23\uff0d25.Bali\/Indonesia<\/li>\n\n\n\n
                                  4. Toyota Y, Hata T, Yamada T,et al\uff1aThe impact of antibiotic use on ICI plus chemotherapy versus chemotherapy in patients with NSCLC and PD-L1 expression of 1% to 49%.ESMO Asia Congress 2024.2024.12.5-9.Singapire<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                    \n
                                    \n

                                    \u56fd\u5185\u7dcf\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                    \n
                                    \n

                                    \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                      \n
                                    1. \u4f0a\u85e4\u660e\u5e83\uff1a\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u8a3a\u65ad\u306b\u304a\u3051\u308b\u30ea\u30dc\u30c6\u30b9\u30c8\u30ec\u30b8\u30aa\u30cd\u30e9\u3068\u30a4\u30e0\u30ce\u30ad\u30e3\u30c3\u30c1\u30ec\u30b8\u30aa\u30cd\u30e9\u306e\u6709\u7528\u6027\u306e\u6bd4\u8f03\u691c\u8a0e~\u4ed6\u65bd\u8a2d\u5171\u540c\u524d\u5411\u304d\u89b3\u5bdf\u7814\u7a76\uff5e. \u4ee4\u548c6\u5e74\u7b2c19\u671fNPO\u6cd5\u4eba\u897f\u65e5\u672c\u547c\u5438\u5668\u5185\u79d1\u533b\u7642\u63a8\u9032\u6a5f\u69cb\u3000\u7dcf\u4f1a.2024.2.3.\u4eac\u90fd<\/li>\n\n\n\n
                                    2. \u7530\u4e2d\u5f69\u52a0\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u5929\u91ce\u660e\u5f66\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u5c71\u91ce\u9686\u53f2\u3001\u77f3\u7530\u3000\u76f4\uff1a\u7d4c\u6c17\u7ba1\u652f\u6027\u30af\u30e9\u30a4\u30aa\u80ba\u751f\u691c\u3092\u65bd\u884c\u3057\u305f\u6297ARS\u6297\u4f53\/\u7b4b\u708e\u95a2\u9023\u6297\u4f53\u967d\u6027\u9593\u8cea\u6027\u80ba\u708e\u75c7\u4f8b\u306e\u691c\u8a0e.\u7b2c64\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2024.4.5.\u795e\u5948\u5ddd<\/li>\n\n\n\n
                                    3. \u9ad9\u6a4b\u3000\u5bdb\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u5c71\u91ce\u9686\u53f2\u3001\u77f3\u7530\u3000\u76f4\uff1a\u6297Ro52\u6297\u4f53\u306f\u6297aminoacyl tRNA\u3000synthetase\u6297\u4f53\u967d\u6027\u306e\u9593\u8cea\u6027\u75be\u60a3\u306b\u304a\u3044\u3066\u518d\u71c3\u30ea\u30b9\u30af\u56e0\u5b50\u306b\u306a\u308a\u3046\u308b. \u7b2c64\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2024.4.7.\u795e\u5948\u5ddd<\/li>\n\n\n\n
                                    4. \u4f0a\u85e4\u660e\u5e83\uff1a\u80baMAC\u75c7\u306e\u65b0\u305f\u306a\u5c55\u958b\u3092\u898b\u636e\u3048\u3066\uff5eGBT\u9075\u5b88\u306e\u73fe\u72b6\u3068\u8ab2\u984c\u3068\u306f\uff5e.\u7b2c99\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2024.6.1.\u9577\u5d0e<\/li>\n\n\n\n
                                    5. \u5929\u91ce\u660e\u5f66\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4e39\u7fbd\u3000\u5d07\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u672b\u68a2\u75c5\u5909\u306ePulmonary Hyalinizing Granuloma\u306e1\u4f8b.\u7b2c47\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2024.6.27.\u5927\u962a<\/li>\n\n\n\n
                                    6. \u677e\u7530\u62d3\u6717\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\uff1a\u7c9f\u7c92\u7d50\u6838\u3068\u306e\u9451\u5225\u3092\u8981\u3057\u305f\u80ba\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306e\u4e00\u4f8b\uff0e\u7b2c44\u56de\u65e5\u672c\u65e5\u672c\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\/\u8089\u82bd\u816b\u6027\u75be\u60a3\u5b66\u4f1a\u7dcf\u4f1a.2024.10.12\uff0e\u5175\u5eab<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                      \n

                                      \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/p>\n\n\n\n

                                        \n
                                      1. \u6a2a\u5c71\u4fca\u79c0\u3001\u6817\u6797\u5fe0\u5f18\u3001\u69c7\u672c\u3000\u525b\u3001\u4e45\u5c71\u3000\u5f70\u3001\u52a0\u85e4\u6709\u52a0\u3001\u5de5\u85e4\u5065\u4e00\u90ce\u3001\u5800\u7530\u5c1a\u514b\u3001\u8431\u8c37\u7d18\u679d\u3001\u4e95\u4e0a\u653f\u662d\u3001\u6749\u672c\u5553\u4ecb\u3001\u5927\u6a4b\u572d\u660e\u3001\u5800\u7530\u52dd\u5e78\uff1aALK\u878d\u5408\u907a\u4f1d\u5b50\u5909\u7570\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u304a\u3051\u308b\u30a2\u30ec\u30af\u30c1\u30cb\u30d6\u65e9\u671f\u8010\u6027\u60a3\u8005\u306e\u81e8\u5e8a\u7684\u7279\u5fb4\u3092\u660e\u3089\u304b\u306b\u3059\u308b\u305f\u3081\u306e\u5f8c\u308d\u5411\u304d\u3002\u30db\u30fc\u30c8\u7814\u7a76. \u7b2c64\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2024.4.6.\u795e\u5948\u5ddd<\/li>\n\n\n\n
                                      2. \u77f3\u7530\u3000\u76f4\uff1a\uff1c\u65e5\u81e8\u5185\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u7814\u7a76\u73ed\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff1eCOVID-19\/\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u306e\u73fe\u6cc1.\u7b2c37\u56de\u65e5\u672c\u81e8\u5e8a\u5185\u79d1\u533b\u5b66\u4f1a\uff0e2024.9.15\uff0e\u4eac\u90fd<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                        \n

                                        \u6559\u80b2\u30bb\u30df\u30ca\u30fc<\/p>\n\n\n\n

                                          \n
                                        1. \u4f0a\u85e4\u660e\u5e83\uff1a\u80ba\u708e\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306e\u4e00\u6b69\u5148\u3092\u884c\u304f\u5e02\u4e2d\u80ba\u708e\u8a3a\u7642\uff5e\u5009\u4e2d\u6d41\u80ba\u708e\u8a3a\u7642\u306e\u6975\u610f\uff5e. \u4ee4\u548c6\u5e74\u5ea6\u7b2c3\u56de\u82e5\u624b\u533b\u5e2b\u306e\u305f\u3081\u306e\u81e8\u5e8a\u306b\u5f79\u7acb\u3064\u547c\u5438\u5668\u30bb\u30df\u30ca\u30fc.2024.7.13.\u5927\u962a<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                          \n
                                          \n

                                          \u56fd\u5185\u5b66\u4f1a\u30fb\u5730\u65b9\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                          \n
                                          \n

                                          \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                            \n
                                          1. \u7dd2\u65b9\u5eb7\u4eba\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u7532\u7530\u62d3\u4e4b\u3001\u77f3\u7530\u3000\u76f4\uff1a\u80ba\u764c\u5316\u5b66\u7642\u6cd5\u4e2d\u306b\u4e88\u9632\u7684G-CSF\u88fd\u5264\u306b\u3088\u308a\u751f\u3058\u305f\u85ac\u5264\u6027\u8840\u7ba1\u708e\u306e\u4e00\u4f8b. \u7b2c70\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.7.19.\u9ce5\u53d6<\/li>\n\n\n\n
                                          2. \u65b0\u5bae\u7950\u4eae\uff1aEBUS-GS\u6cd5\u3067\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u80ba\u653e\u7dda\u83cc\u75c7\u306e\u4e00\u4f8b. \u7b2c70\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.7.19.\u9ce5\u53d6<\/li>\n\n\n\n
                                          3. \u6ff1\u5ddd\u6b63\u5149\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u597d\u9178\u7403\u6027\u80ba\u708e\u5408\u4f75\u75c7type2\u708e\u75c7\u75be\u60a3\u306b\u5bfe\u3059\u308b\u30c7\u30e5\u30d4\u30eb\u30de\u30d6\u306e\u5fcd\u5bb9\u6027\u306b\u95a2\u3059\u308b3\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c70\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.7.20.\u9ce5\u53d6<\/li>\n\n\n\n
                                          4. \u5929\u91ce\u660e\u5f66\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u77f3\u7530\u3000\u76f4\uff1a\u786c\u819c\u8ee2\u79fb\u306b\u3088\u3063\u3066\u8996\u529b\u969c\u5bb3\u3092\u304d\u305f\u3057\u305f\u80ba\u817a\u764c\u306e\u4e00\u4f8b.\u7b2c62\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.7.19.\u9ce5\u53d6<\/li>\n\n\n\n
                                          5. \u9ad9\u6a4b\u3000\u5bdb\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u304c\u8a3a\u65ad\u306b\u5bc4\u4e0e\u3057\u305f\u3001\u3073\u307e\u3093\u6027\u30b9\u30ea\u30ac\u30e9\u30b9\u9670\u5f71\u3092\u5448\u3057\u305f\u3073\u307e\u3093\u6027\u80ba\u77f3\u7070\u5316\u75c7\u306e\uff11\u4f8b. \u7b2c70\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.7.20.\u9ce5\u53d6<\/li>\n\n\n\n
                                          6. \u9ad9\u6a4b\u3000\u5bdb\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u77f3\u7530\u3000\u76f4\uff1a\u9f3b\u54bd\u982dPCR\u691c\u67fb\u306f\u9670\u6027\u3060\u3063\u305f\u304c\u3001\u6c17\u7ba1\u652f\u80da\u80de\u6d17\u6d44\u6db2\u306eFilmArray\u30d1\u30cd\u30eb\u691c\u67fb\u3067\u8a3a\u65ad\u3057\u305fCOVID-19\u518d\u6d3b\u6027\u5316\u306e1\u4f8b.\u7b2c71\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.11.30.\u9ad8\u77e5<\/li>\n\n\n\n
                                          7. \u6ff1\u5ddd\u6b63\u5149\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u5929\u91ce\u660e\u5f66\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\uff1a\u7279\u767a\u6027\u6162\u6027\u597d\u9178\u7403\u6027\u80ba\u708e\u306b\u5bfe\u3057\u3066\u30e1\u30dd\u30ea\u30ba\u30de\u30d6\u3092\u9577\u671f\u6295\u4e0e\u3057\u305f\uff13\u75c7\u4f8b\u306e\u691c\u8a0e\uff0e\u7b2c71\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.11.30.\u9ad8\u77e5<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                            \n

                                            \u30bb\u30df\u30ca\u30fc<\/p>\n\n\n\n

                                              \n
                                            1. \u798f\u7530\u3000\u6cf0\uff1a\u2163\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6226\u7565 \uff5e\u514d\u75ab\u95a2\u9023\u6709\u5bb3\u4e8b\u8c61\u3092\u4e57\u308a\u8d8a\u3048\u9577\u671f\u751f\u5b58\u3092\u5c4a\u3051\u308b\u305f\u3081\u306b\u4f55\u304c\u51fa\u6765\u308b\u304b\uff5e. \u7b2c92\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u3000\u6625\u5b63\u5b66\u8853\u96c6.2024.3.16.\u718a\u672c<\/li>\n\n\n\n
                                            2. \u798f\u7530\u3000\u6cf0\uff1aALK\u967d\u6027\u80ba\u764c\u306e\u6700\u9069\u306a\u6cbb\u7642\u9078\u629e\u3092\u76ee\u6307\u3057\u3066\uff5e\u3069\u3046\u3059\u308b\u521d\u56de\u6cbb\u7642\uff5e. \u7b2c62\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u652f\u90e8\u5b66\u8853\u96c6\u4f1a.2024.7.19.\u9ce5\u53d6<\/li>\n\n\n\n
                                            3. \u4f0a\u85e4\u660e\u5e83\uff1a\u75c7\u4f8b\u3092\u901a\u3058\u3066\u5b66\u3076MAC\u75c7\u8a3a\u7642\u306e\u6975\u610f. \u7b2c70\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2024.7.20.\u9ce5\u53d6<\/li>\n\n\n\n
                                            4. \u4f0a\u85e4\u660e\u5e83\uff1a\u65b0\u305f\u306a\u5c55\u958b\u3092\u8fce\u3048\u305f\u80baMAC\u75c7\u8a3a\u7642\uff5e\u6700\u65b0\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u3082\u3068\u306b\u80baMAC\u75c7\u306e\u6700\u65b0\u6cbb\u7642\u3092\u8003\u3048\u308b\uff5e. \u7b2c26\u56de\u65e5\u672c\u54b3\u55fd\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.2024.9.28.\u77f3\u5ddd<\/li>\n\n\n\n
                                            5. \u798f\u7530\u3000\u6cf0\uff1a\u2163\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6226\u7565\uff5ePD-L1\u9670\u6027\u306b\u6311\u3080\uff5e.\u7b2c71\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff0e2024.11.30.\u9ad8\u77e5<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                              \n
                                              \n

                                              2023\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                              \n
                                              \n
                                              \n

                                              \u56fd\u969b\u5b66\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                              \n
                                                \n
                                              1. Yamano T, Arita M\u3001Tanaka A, Hamakawa M, Ishida T\uff1aFrequency and background of progressive fibrosing interstitial lung disease(PF-ILD) in anti-aminoacyl tRNA synthetase(ARS) antibody-positive interstitial lung disease. European Respiratory Society  International Congress\u30002023.9.9-13.MIRANO.<\/li>\n\n\n\n
                                              2. Ito A, Ishida T, Nakanishi Y, Kawataki M,Tachibana H\uff1aIdentification rate of Legionella species in non-purulent sputum culture is comparable to that in purulent sputum culture in Legionella pneumonia: A retrospective. APSR2023.2023.11.16-19.Singapore<\/li>\n\n\n\n
                                              3. Takahashi H, Hamakawa M, Arita M, Tachibana H, Ishida T\uff1aInvestigation of factors likely to complete remission in Japanese patients with EGPA. APSR2023.2023.11.16-19.Singapore<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                \n
                                                \n

                                                \u56fd\u5185\u7dcf\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                \n
                                                \n

                                                \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                  \n
                                                1. \u7530\u4e2d\u5f69\u52a0\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u5c71\u91ce\u9686\u53f2\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u77f3\u7530\u3000\u76f4\uff1a\u7d4c\u6c17\u7ba1\u652f\u30af\u30e9\u30a4\u30aa\u80ba\u751f\u691c\u3092\u65bd\u884c\u3057multi-disciplinary discussio (MDD) \u3067\u8a3a\u65ad\u3057\u305f\u7dda\u7dad\u6027\u904e\u654f\u6027\u80ba\u708e\uff08\uff46HP)\u75c7\u4f8b\u306e\u691c\u8a0e.\u7b2c63\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.4.28.\u6771\u4eac.<\/li>\n\n\n\n
                                                2. \u6ff1\u5ddd\u6b63\u5149\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u798f\u7530\u3000\u6cf0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308bEGPA37\u75c7\u4f8b\u306e\u81e8\u5e8a\u7684\u5bdb\u89e3\u56e0\u5b50\u306e\u691c\u8a0e.\u7b2c63\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.4.29.\u6771\u4eac.<\/li>\n\n\n\n
                                                3. \u5c71\u91ce\u9686\u53f2\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u77f3\u7530\u3000\u76f4\uff1a\u6297aminoacyl tRNA synthetase \u6297\u4f53\u967d\u6027\u306e\u9593\u8cea\u6027\u80ba\u75be\u60a3\u306b\u304a\u3051\u308b\u9032\u884c\u6027\u7dda\u7dad\u5316\u3092\u4f34\u3046\u9593\u8cea\u6027\u80ba\u75be\u60a3\uff08PF-ILD)\u75c7\u4f8b\u306e\u691c\u8a0e.\u7b2c63\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.4.29.\u6771\u4eac.<\/li>\n\n\n\n
                                                4. \u5c71\u91ce\u9686\u53f2\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u798f\u7530\u3000\u6cf0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u4e39\u7fbd\u3000\u5d07\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u30ed\u30fc\u30d6\u3092\u7528\u3044\u305f\u7c98\u6db2\u6813\u9664\u53bb\u3067\u7121\u6c17\u80ba\u3092\u89e3\u9664\u3057\u5f97\u305f\u30a2\u30ec\u30eb\u30ae\u30fc\u6027\u6c17\u7ba1\u652f\u80ba\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u75c7\u306e\u4e00\u4f8b.\u7b2c46\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.6.30.\u6a2a\u6d5c.<\/li>\n\n\n\n
                                                5. \u7530\u4e2d\u5f69\u52a0\u3001\u4e39\u7fbd\u3000\u5d07\u3001\u5c71\u91ce\u9686\u53f2\u3001\u4f50\u85e4\u4eae\u5bff\u3001\u9ad8\u7530\u6b63\u6d69\u3001\u672c\u5009\u512a\u7f8e\u3001\u7530\u5c3e\u6709\u91cc\u3001\u795e\u6238\u5bdb\u53f2\u3001\u7532\u7530\u62d3\u4e4b\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u786c\u6027\u6c17\u7ba1\u652f\u93e1\u4e0b\u306b\u9577\u671f\u9593\u5d4c\u9813\u3057\u3066\u3044\u305f\u6c17\u7ba1\u652f\u7570\u7269\u3092\u6458\u51fa\u3057\u305f1\u4f8b.\u7b2c46\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.6.29.\u6a2a\u6d5c.<\/li>\n\n\n\n
                                                6. \u798f\u7530\u3000\u6cf0\u3001\u5bae\ufa11\u7531\u4f9d\u3001\u8c4a\u7530\u88d5\u58eb\u3001\u5c71\u91ce\u9686\u53f2\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u75c7\u72b6\u7de9\u548c\u306b\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u30ab\u30eb\u30c1\u30ce\u30a4\u30c9\u306e\u4e00\u4f8b.\u7b2c46\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.6.29.\u6a2a\u6d5c.<\/li>\n\n\n\n
                                                7. \u5bae\ufa11\u7531\u4f9d\u3001\u798f\u7530\u3000\u6cf0\u3001\u5c71\u91ce\u9686\u53f2\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83;\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u691c\u8a3a\u306e\u80f8\u90e8\uff38\u7dda\u5199\u771f\u3067\u6c17\u7ba1\u72ed\u7a84\u3092\u6307\u6458\u3055\u308c\u3001\u6c17\u7ba1\u652f\u93e1\u691c\u67fb\u3067\u6c17\u7ba1\u6c17\u7ba1\u652f\u9aa8\u8edf\u9aa8\u7570\u5f62\u6210\u75c7\u3068\u8a3a\u65ad\u3057\u305f\u4e00\u4f8b. \u7b2c46\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.6.29.\u6a2a\u6d5c.<\/li>\n\n\n\n
                                                8. \u5bae\ufa11\u7531\u4f9d. \u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u5409\u7530\u5c06\u548c\u3001\u5c0f\u6797\u6b63\u55e3\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u53f3\u80ba\u5168\u6458\u8853\u5f8c\u65e9\u671f\u306b\u518d\u767a\u3057\u305f\u80ba\u539f\u767a\u6ed1\u819c\u8089\u816b\u306e\u4e00\u4f8b.\u7b2c64\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.11.2.\u5343\u8449.<\/li>\n\n\n\n
                                                9. \u6a2a\u5c71\u4fca\u79c0\u3001\u4ef2\u5730\u4e00\u90ce\u3001\u8352\u4e95\u5927\u8f14\u3001\u9f4b\u85e4\u3000\u5408\u3001\u7530\u5bae\u57fa\u88d5\u3001\u539f\u3000\u8061\u5fd7\u3001\u7a81\u7530\u5bb9\u5b50\u3001\u677e\u672c\u5553\u5b5d\u3001\u5cb8\u5ddd\u5b5d\u4e4b\u3001\u9ad8\u5ca9\u5353\u4e5f\u3001\u5ca1\u7530\u3042\u3059\u304b\u3001\u5bfa\u5ca1\u4fca\u8f14\uff1aMET exon 14 skipping\u967d\u6027\u80ba\u764c\u306b\u898b\u3089\u308c\u308b\u81e8\u5e8a\u7684\u7279\u5fb4\u3068\u6cbb\u7642\u52b9\u679c\u306b\u3064\u3044\u3066. \u7b2c64\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.11.3.\u5343\u8449.<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                  \n

                                                  \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/p>\n\n\n\n

                                                    \n
                                                  1. \u77f3\u7530\u3000\u76f4\uff1a\u300c\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3000Up to Date\u300d.\u7b2c97\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. 2023.4.28.\u6a2a\u6d5c.2023<\/li>\n\n\n\n
                                                  2. \u4f0a\u85e4\u660e\u5e83\uff1a\u89b3\u5bdf\u7814\u7a76\u3092\u3044\u304b\u306b\u3046\u307e\u304f\u7acb\u6848\u30fb\u5b9f\u884c\u3057\u8ad6\u6587\u5316\u306b\u3064\u306a\u3052\u308b\u304b\uff5e\u5f53\u9662\u306b\u304a\u3051\u308b\u80ba\u708e\u524d\u5411\u304d\u89b3\u5bdf\u7814\u7a76\u306e\u5b9f\u969b\uff5e.\u7b2c63\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.4.29.\u6771\u4eac.<\/li>\n\n\n\n
                                                  3. \u4f0a\u85e4\u660e\u5e83\uff1a\u80baMAC\u75c7\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8\u306e\u5411\u4e0a\u3092\u76ee\u6307\u3057\u3066.\u7b2c98\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.6.10.\u6771\u4eac.<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                    \n

                                                    \u6559\u80b2\u30bb\u30df\u30ca\u30fc<\/p>\n\n\n\n

                                                      \n
                                                    1. \u4f0a\u85e4\u660e\u5e83\uff1a\u65e5\u672c\u306b\u304a\u3044\u3066 PCT \u30ac\u30a4\u30c9\u4e0b\u6297\u83cc\u85ac\u6cbb\u7642\u306f\u4e0d\u8981\u306a\u306e\u304b\uff1f \u301c\u65e5\u672c\u7248 PCT \u30ac\u30a4\u30c9\u4e0b\u6297\u83cc\u85ac\u6cbb\u7642\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u4f5c\u6210\u306b\u3042\u305f\u308a\u301c. \u7b2c50\u56de\u3000\u65e5\u672c\u96c6\u4e2d\u6cbb\u7642\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2023.3.1\uff0d2.\u4eac\u90fd.<\/li>\n\n\n\n
                                                    2. \u4f0a\u85e4\u3000\u660e\u5e83\uff1a\u65b0\u305f\u306a\u5c55\u958b\u3092\u8fce\u3048\u305f\u80baMAC\u75c7\u8a3a\u7642\uff5e\u56fd\u5185\u5916\u306e\u6700\u65b0\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3092\u4e2d\u5fc3\u306b\u8003\u5bdf\u3059\u308b\uff5e.\u7b2c72\u56de\u65e5\u672c\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.2023.10.20.\u6771\u4eac.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                      \n
                                                      \n

                                                      \u56fd\u5185\u5b66\u4f1a\u30fb\u5730\u65b9\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                      \n
                                                      \n

                                                      \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                        \n
                                                      1. \u4f50\u85e4\u4eae\u5bff\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e0a\u7530\u6566\u5fd7\u3001\u795e\u6238\u5bdb\u53f2\u3001\u77f3\u7530\u3000\u76f4\uff1a\u540c\u7a2e\u81cd\u5e2f\u8840\u79fb\u690d4\u5e74\u534a\u5f8c\u306b\u30cb\u30e5\u30fc\u30e2\u30b7\u30b9\u30c1\u30b9\u80ba\u708e\u3092\u767a\u75c7\u3057\u305f\u4e00\u4f8b. \u7b2c128\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e2d\u56fd\u5730\u65b9\u4f1a.2023.5\u3001.21.\u5ca1\u5c71.<\/li>\n\n\n\n
                                                      2. \u9ad8\u6a4b\u3000\u5bdb\uff1a\uff1c\u75c7\u4f8b\u691c\u8a0e\u4f1a\uff1eICI\u6295\u4e0e\u4e2d\u306b\u9593\u8cea\u6027\u9670\u5f71\u3092\u8a8d\u3081\u305f1\u4f8b. \u7b2c68\u56de\u3000\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.7.16.\u9999\u5ddd.<\/li>\n\n\n\n
                                                      3. \u9ad9\u6a4b\u3000\u5bdb\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6e21\u908a\u3000\u54f2\u3001\u77f3\u7530\u3000\u76f4\uff1aAspf1\u304c\u8a3a\u65ad\u306b\u5bc4\u4e0e\u3057\u3048\u305fSchizophyllum commune\u306b\u3088\u308b\u30a2\u30ec\u30eb\u30ae\u30fc\u6027\u6c17\u7ba1\u652f\u80ba\u771f \u83cc\u75c7\u306e1\u4f8b. \u7b2c68\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.7.15.\u9999\u5ddd.<\/li>\n\n\n\n
                                                      4. \u5929\u91ce\u660e\u5f66\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f50\u85e4\u4eae\u5bff\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1alenvatinib\u306e\u518d\u6295\u4e0e\u3092\u884c\u3063\u305f\u9ad8\u9f62\u8005\u80f8\u817a\u764c\u306e1\u4f8b\uff0e\u7b2c68\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a2023.7.15.\u9999\u5ddd.<\/li>\n\n\n\n
                                                      5. \u677e\u4e95\u99a8\u5b50\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u77f3\u7530\u3000\u76f4\uff1a\u80ba\u80de\u51fa\u8840\u3067\u767a\u75c7\u3057\u305f\u3001\u30d7\u30ed\u30d4\u30eb\u30c1\u30aa\u30a6\u30ed\u30b7\u30eb\u306b\u3088\u308b\u85ac\u5264\u8a98\u767a\u6027ANCA\u95a2\u9023\u8840\u7ba1\u708e\u306e\u4e00\u4f8b. \u7b2c68\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a2023.7.15.\u9999\u5ddd.<\/li>\n\n\n\n
                                                      6. \u9ad9\u6a4b\u3000\u5bdb\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u897f\u6751\u5553\u4f51\u3001\u77f3\u7530\u3000\u76f4\uff1a\u591a\u5f69\u306a\u80ba\u75c5\u5909\u304c\u518d\u767a\u6027\u591a\u767a\u8edf\u9aa8\u708e\u3068\u306e\u9451\u5225\u306b\u6709\u7528\u3067\u3042\u3063\u305fVEXAS\u75c7\u5019\u7fa4\u306e1\u4f8b. \u7b2c69\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.12.16.\u5fb3\u5cf6.<\/li>\n\n\n\n
                                                      7. \u5ddd\u7027\u6b63\u5178\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u7532\u7530\u62d3\u4e4b\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u56a2\u80de\u6027\u75c5\u5909\u3092\u6709\u3059\u308bIgG4\u95a2\u9023\u80ba\u75be\u60a3\u306e\u6cbb\u7642\u65b9\u91dd\u306b\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u80ba\u751f\u691c\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u4e00\u4f8b. \u7b2c69\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.12.17.\u5fb3\u5cf6.<\/li>\n\n\n\n
                                                      8. \u7dd2\u65b9\u5eb7\u4eba\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u7532\u7530\u62d3\u4e4b\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\uff1aARDS\u3092\u5448\u3057\u8a3a\u65ad\u304c\u9045\u308c\u305f\u7c9f\u7c92\u7d50\u6838\u306e\u4e00\u4f8b. \u7b2c69\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.12.17.\u5fb3\u5cf6.<\/li>\n\n\n\n
                                                      9. \u65e9\u702c\u767e\u3005\u5b50\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u5ca1\u7530\u548c\u4e5f\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30aa\u30d3\u30cc\u30c4\u30ba\u30de\u30d6\u6295\u4e0e\u4e2d\u306b\u767a\u75c7\u3057\u305fCOVID-19\u9077\u5ef6\u6027\u80ba\u969c\u5bb3\u306e1\u4f8b. \u7b2c69\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.12.17.\u5fb3\u5cf6.<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                        \n

                                                        \u30bb\u30df\u30ca\u30fc<\/p>\n\n\n\n

                                                          \n
                                                        1. \u6a2a\u5c71\u4fca\u79c0\uff1a\u30c9\u30e9\u30a4\u30d0\u30fc\u907a\u4f1d\u5b50\u5909\u7570\u9670\u6027\u9032\u884c\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306eTips. \u7b2c61\u56de\u3000\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.7.15.\u9999\u5ddd.<\/li>\n\n\n\n
                                                        2. \u798f\u7530\u3000\u6cf0\uff1a\u2163\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6226\u7565\uff5eirAE\u3092\u4e57\u308a\u8d8a\u3048\u3066\u9577\u671f\u751f\u5b58\u3092\u5c4a\u3051\u308b\u305f\u3081\u306b\uff5e. \u7b2c61\u56de\u3000\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.20223.7.16.\u9999\u5ddd.<\/li>\n\n\n\n
                                                        3. \u798f\u7530\u3000\u6cf0\uff1a\u5b9f\u5730\u81e8\u5e8a\u3067\u306eNIVO+IPI\u00b1Chemo\u3000\u30a8\u30d3\u30c7\u30f3\u30b9\u3068\u4f7f\u7528\u7d4c\u9a13Update.\u7b2c69\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2023.12.16.\u5fb3\u5cf6.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                          \n
                                                          \n

                                                          2023\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                          \n
                                                          \n
                                                          \n

                                                          \u56fd\u969b\u5b66\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                          \n
                                                            \n
                                                          1. Yokoyama T, Sakamoto T, Matsubara T, Takahama T, et all: A project to investigate the actual status of biomarker testing in unresectable advanced or recurrent non-small cell lung cancer:WJOG15421L(REVEAL). IASLC\u3000Asia Conference on Lung Cancer. 2022.10.22-29. WEB<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                            \n
                                                            \n

                                                            \u56fd\u5185\u7dcf\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                            \n
                                                            \n

                                                            \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                              \n
                                                            1. Fukuda Y, Yoshioka H, Hata T, Washio Y, Furuuchi K, Takei R, Yamazaki A, aga M, Kumagai S, Nishihara T, Tanaka T, Yamagata A, Momose M, Nakanishi Y, Yamanaka Y, Kaneda T, Niwa T, Yokoyama T, Kurata T, Ishida T: Safety and feasibility of hyper short-hydration using furosemide in cisplatin-based chemotherapy.\u7b2c19\u56de\u65e5\u672c\u81e8\u5e8a\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.2.17-19.\u4eac\u90fd.<\/li>\n\n\n\n
                                                            2. \u5929\u91ce\u660e\u5f66\u3001\u798f\u7530\u3000\u6cf0\u3001\u795e\u6238\u5bdb\u53f2\u3001\u591a\u7530\u6709\u4f5c\u3001\u5c71\u91ce\u9686\u53f2\u3001\u5ddd\u7027\u6b63\u5178\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4e2d\u897f\u967d\u7950\u3001\u767e\u702c\u3000\u5321\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u3067\u8a3a\u65ad\u3055\u308c\u305f\u80ba\u8089\u816b\u69d8\u80ba\u764c15\u4f8b\u306e\u8a3a\u65ad\u65b9\u6cd5\u306e\u691c\u8a0e.\u7b2c62\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2022.4.22-24.\u4eac\u90fd<\/li>\n\n\n\n
                                                            3. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\uff1a65\u6b73\u4ee5\u4e0a\u306e\u5f53\u79d1\u5916\u6765\u901a\u9662\u60a3\u8005\u306b\u304a\u3051\u308b\u80ba\u708e\u7403\u83cc\u30ef\u30af\u30c1\u30f3\u63a5\u7a2e\u72b6\u6cc1\u306e\u691c\u8a0e.\u7b2c96\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.2022.2.22.\u57fc\u7389<\/li>\n\n\n\n
                                                            4. \u8c4a\u7530\u88d5\u58eb\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u795e\u6238\u5bdb\u53f2\u3001\u5929\u91ce\u660e\u5f66\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u677e\u4e95\u99a8\u5b50\uff0c\u5bae\ufa11\u7531\u4f9d\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u80baMAC\u75c7\u306b\u304a\u3044\u3066MAC\u6297\u4f53\u6e2c\u5b9a\u306f\u6cbb\u7642\u5fc5\u8981\u6027\u306e\u4e88\u6e2c\u306b\u6709\u7528\u304b.\u7b2c97\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a.2022.7.1-2.\u65ed\u5ddd<\/li>\n\n\n\n
                                                            5. \u677e\u4e95\u99a8\u5b50\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u795e\u6238\u5bdb\u53f2\u3001\u5929\u91ce\u660e\u5f66\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u8c4a\u7530\u88d5\u58eb\uff0c\u5bae\ufa11\u7531\u4f9d\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u80baMAC\u75c7\u6cbb\u7642\u5b8c\u9042\u5f8c\u306e\u518d\u6392\u83cc\u30ea\u30b9\u30af\u306e\u691c\u8a0e. \u7b2c97\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a.2022.7.1-2.\u65ed\u5ddd<\/li>\n\n\n\n
                                                            6. \u5929\u91ce\u660e\u5f66\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u795e\u6238\u5bdb\u53f2\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u8c4a\u7530\u88d5\u58eb\uff0c\u5bae\ufa11\u7531\u4f9d\u3001\u677e\u4e95\u99a8\u5b50\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u30fb\u751f\u7269\u5b66\u7684\u88fd\u5264\u6cbb\u7642\u4e2d\u306e\u80baMAC\u75c7\u306e\u6cbb\u7642\u7d4c\u904e\u306e\u691c\u8a0e. \u7b2c97\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a.2022.7.1-2.\u65ed\u5ddd<\/li>\n\n\n\n
                                                            7. \u5bae\ufa11\u7531\u4f9d\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u795e\u6238\u5bdb\u53f2\u3001\u5929\u91ce\u660e\u5f66\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u8c4a\u7530\u88d5\u58eb\uff0c\u677e\u4e95\u99a8\u5b50\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u7121\u6cbb\u7642\u7d4c\u904e\u89b3\u5bdf\u4e2d\u306b\u6cbb\u7642\u5c0e\u5165\u3092\u8981\u3057\u305f\u80baMAC\u75c7\u60a3\u8005\u306e\u691c\u8a0e. \u7b2c97\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u30fb\u5b66\u8853\u8b1b\u6f14\u4f1a.2022.7.1-2.\u65ed\u5ddd<\/li>\n\n\n\n
                                                            8. \u795e\u6238\u5bdb\u53f2\uff1a\u521d\u56de\u30d7\u30e9\u30c1\u30ca\u4f75\u7528+\u514d\u75ab\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u85ac\u7642\u6cd5\u306b\u304a\u3051\u308b\u8133\u8ee2\u79fb\u3068\u6cbb\u7642\u52b9\u679c\u306b\u95a2\u3059\u308b\u591a\u65bd\u8a2d\u5f8c\u5411\u89b3\u5bdf\u7814\u7a76.\u7b2c63\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.12.1.\u798f\u5ca1<\/li>\n\n\n\n
                                                            9. \u798f\u7530\u3000\u6cf0\uff1a\u5f53\u9662\u3067\u8a3a\u65ad\u3057\u305f\u80ba\u8089\u816b\u69d8\u764c 15 \u4f8b\u306e\u691c\u8a0e.\u7b2c63\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.12.1.\u798f\u5ca1<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                              \n

                                                              \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/p>\n\n\n\n

                                                                \n
                                                              1. \u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u795e\u6238\u5bdb\u53f2\u3001\u5929\u91ce\u660e\u5f66\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u8c4a\u7530\u88d5\u58eb\u3001\u5bae\ufa11\u7531\u4f9d\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a75\u6b73\u4ee5\u4e0a\u306e\u9ad8\u9f62\u80baMAC\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u6cbb\u7642\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u306e\u691c\u8a0e. \u7b2c97\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a.2022.7.1-2.\u65ed\u5ddd<\/li>\n\n\n\n
                                                              2. \u9ad9\u6a4b\u3000\u5bdb\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u795e\u6238\u5bdb\u53f2\u3001\u5929\u91ce\u660e\u5f66\u3001\u8c4a\u7530\u88d5\u58eb\u3001\u677e\u4e95\u99a8\u5b50\u3001\u5bae\ufa11\u7531\u4f9d\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u80baMAC\u75c7\u306e\u6a19\u6e96\u6cbb\u7642\u306b\u304a\u3051\u308b\u526f\u4f5c\u7528\u306e\u691c\u8a0e. \u7b2c97\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a.2022.7.1-2.\u65ed\u5ddd<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                                \n

                                                                \u7279\u5225\u8b1b\u6f14<\/p>\n\n\n\n

                                                                  \n
                                                                1. \uff1c\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff1e\u4f0a\u85e4\u660e\u5e83\uff1a COV0ID-19\u3000\u8a3a\u7642\u306b\u304a\u3051\u308b\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u3092\u8003\u3048\u308b\uff5e\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u6e2c\u5b9a\u306f\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u306b\u6709\u7528\u306a\u306e\u304b\uff1f\uff5e.\u7b2c49\u56de\u65e5\u672c\u96c6\u4e2d\u6cbb\u7642\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.3.19.WEB.2022.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                  \n
                                                                  \n

                                                                  \u56fd\u5185\u5730\u65b9\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                  \n
                                                                  \n

                                                                  \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                                    \n
                                                                  1. \u9ad9\u6a4b\u3000\u5bdb\u3001\u795e\u6238\u5bdb\u53f2\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u7532\u7530\u62d3\u4e4b\u3001\u57a3\u5185\u7f8e\u6ce2\u3001\u77f3\u7530\u3000\u76f4\uff1a\u9593\u8cea\u6027\u80ba\u708e\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u3001\u5256\u691c\u306b\u81f3\u3063\u305f\u5287\u75c7\u578b\u507d\u819c\u6027\u8178\u708e\u306e\u4e00\u4f8b.\u7b2c66\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.7.9.\u5c71\u53e3<\/li>\n\n\n\n
                                                                  2. \u672c\u5009\u512a\u7f8e\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u7530\u5c3e\u6709\u91cc\u3001\u77f3\u7530\u3000\u76f4\uff1aCOVID-19\u3068\u91cd\u8907\u611f\u67d3\u3057\u305f\u91cd\u75c7\u30a2\u30c7\u30ce\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u4e00\u4f8b.\u7b2c92\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.11.3.\u9577\u5d0e<\/li>\n\n\n\n
                                                                  3. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u6642\u5ca1\u53f2\u660e\uff1a\u30e9\u30b9\u30af\u30d5\u30ed\u30ad\u30b5\u30b7\u30f3\u6295\u4e0e\u304c\u6709\u52b9\u3067\u3042\u3063\u305f\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u306e1\u4f8b. \u7b2c92\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.11.4.\u9577\u5d0e<\/li>\n\n\n\n
                                                                  4. \u795e\u6238\u5bdb\u53f2\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u5929\u91ce\u660e\u5f66\u3001\u9ad9\u6a4b\u3000\u5bdb\u3001\u8c4a\u7530\u88d5\u58eb\u3001\u677e\u4e95\u99a8\u5b50\u3001\u5bae\ufa11\u7531\u4f9d\u3001\u4e2d\u897f\u967d\u7950\u3001\u77f3\u7530\u3000\u76f4\uff1a\u80baMAC\u75c7\u8a3a\u65ad\u306b\u304a\u3044\u3066\u3001\u5c0f\u5ddd\u57f9\u5730\u306b\u6db2\u4f53\u57f9\u5730\u3092\u4f75\u7528\u3059\u308b\u3053\u3068\u306f\u65e9\u671f\u8a3a\u65ad\u306b\u304a\u3044\u3066\u6709\u7528\u3067\u3042\u308b. \u7b2c92\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.2022.11.4.\u9577\u5d0e<\/li>\n\n\n\n
                                                                  5. \u5bae\ufa11\u7531\u4f9d\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\u3001\u5bae\u90e8\u79c0\u6643\uff1a\u4e73\u764c\u306b\u5bfe\u3059\u308bAtezolizumab\u6cbb\u7642\u4e2d\u306b\u30b5\u30eb\u30b3\u30a4\u30c9\u69d8\u8089\u82bd\u816b\u6027\u53cd\u5fdc\u3092\u8a8d\u3081\u305f71\u6b73\u5973\u6027\u306e\u4e00\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  6. \u9ad8\u7530\u6b63\u6d69\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5c0f\u7d30\u80de\u80ba\u764c\u3078\u306e\u79d1\u5b66\u7642\u6cd5\u5c0e\u5165\u5f8c\uff0c\u7dd1\u81bf\u83cc\u306b\u3088\u308b\u80ba\u5316\u81bf\u75c7\u3092\u767a\u75c7\u3057\u80ba\u8449\u5207\u9664\u3092\u8981\u3057\u305f1\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  7. \u4f50\u85e4\u4eae\u5bff\u3001\u4e2d\u897f\u967d\u7950\u3001\u9ad8\u7530\u6b63\u6d69\u3001\u7530\u5c3e\u6709\u91cc\u3001\u672c\u5009\u512a\u7f8e\u3001\u591a\u7530\u6709\u4f5c\u3001\u795e\u6238\u5bdb\u53f2\u3001\u5c71\u91ce\u9686\u53f2\u3001\u5ddd\u7027\u6b63\u5178\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u7532\u7530\u62d3\u4e4b\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u306b\u3088\u308b\u6709\u763b\u6027\u81bf\u80f8\u306e\u4e00\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  8. \u5bae\ufa11\u7531\u4f9d\u3001\u795e\u6238\u5bdb\u53f2\u3001\u767e\u702c\u3000\u5321\u3001\u897f\u539f\u5343\u52a0\u3001\u5409\u7530\u77e5\u5b8f\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u9855\u5fae\u93e1\u7684\u591a\u767a\u8840\u7ba1\u708e\u6cbb\u7642\u4e2d\u306b\u5580\u8840\u304c\u9077\u5ef6\u3057\u3001\u75c5\u7406\u89e3\u5256\u3067\u4fb5\u8972\u6027\u80ba\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u75c7\u3068\u8a3a\u65ad\u3057\u305f\u4e00\u5256\u691c\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  9. \u677e\u4e95\u99a8\u5b50\u3001\u795e\u6238\u5bdb\u53f2\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u57a3\u5185\u7f8e\u6ce2\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u521d\u8a8d\u77e5\u75c7\u3068\u8a3a\u65ad\u3055\u308c\u6025\u6fc0\u306b\u5897\u60aa\u3059\u308b\u547c\u5438\u4e0d\u5168\u3092\u5408\u4f75\u3057\u5256\u691c\u306b\u3066\u7c9f\u7c92\u7d50\u6838\u3068\u5224\u660e\u3057\u305f\u4e00\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  10. \u672c\u5009\u512a\u7f8e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u5c71\u91ce\u9686\u53f2\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4e39\u7fbd\u3000\u5d07\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u306e\u5408\u4f75\u75c7\u306e\u691c\u8a0e.\u7b2c31\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u652f\u90e8\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  11. \u8c4a\u7530\u88d5\u58eb\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u5bae\ufa11\u7531\u4f9d\u3001\u5929\u91ce\u660e\u5f66\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305f\u813e\u7d50\u6838\u75c7\u306e1\u4f8b.\u7b2c73\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u652f\u90e8\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  12. \u795e\u6238\u5bdb\u53f2\u3001\u798f\u7530\u3000\u6cf0\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30d2\u30c9\u30ed\u30ad\u30b7\u30ab\u30eb\u30d0\u30df\u30c9\uff08\u30cf\u30a4\u30c9\u30ec\u30a2\u00ae\uff09\u306b\u3088\u308b\u91cd\u75c7\u85ac\u5264\u6027\u80ba\u708e\u3092\u767a\u75c7\u3057\u305f1\u5256\u691c\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.17.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  13. \u65e9\u702c\u767e\u3005\u5b50\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\u3001\u6642\u5ca1\u53f2\u660e\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u798f\u7530\u3000\u6cf0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u7532\u7530\u62d3\u4e4b\u3001\u5ddd\u7027\u6b63\u5178\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u30ef\u30af\u30c1\u30f3\u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u304c\u7591\u308f\u308c\u305f2\u75c7\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.17.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                  14. \u798f\u7530\u3000\u6cf0\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4e2d\u897f\u967d\u7950\u3001\u6ff5\u5c3e\u4fe1\u53d4\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u4fb5\u8972\u6027\u80ba\u708e\u7403\u83cc\u611f\u67d3\u75c7\u3092\u5408\u4f75\u3057\u305fCOVID-19\u306e\u4e00\u4f8b. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.17.\u5ca1\u5c71<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                                    \n

                                                                    \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/p>\n\n\n\n

                                                                      \n
                                                                    1. <\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30bb\u30df\u30ca-> \u6a2a\u5c71\u4fca\u79c0\uff1a\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u85ac\u306e\u4f7f\u3044\u3069\u3053\u308d\uff0dEGFR\u907a\u4f1d\u5b50\u5909\u7570\u967d\u6027\u80ba\u764c.\u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.16.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                    2. <\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30bb\u30df\u30ca-> \u798f\u7530\u3000\u6cf0\uff1a\u80ba\u764c\u6cbb\u7642\u306e\u300cClinical Questions\u300d\u3092\u518d\u8003\u3059\u308b.\u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.17.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                    3. \uff1c3\u5b66\u4f1a\u5408\u540c\u7279\u5225\u4f01\u753b\uff1eAdvances in Respiratory Medicine \u4f0a\u85e4\u660e\u5e83\uff1a\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7 UP-to-date. \u7b2c67\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2022.12.17.\u5ca1\u5c71<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                                        \n
                                                                      1. <\/li>\n<\/ol>\n\n\n\n
                                                                        \n

                                                                        \u7279\u5225\u8b1b\u6f14<\/p>\n\n\n\n

                                                                          \n
                                                                        1. \uff1c\u82e5\u624b\u5411\u3051\u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3\uff1e \u77f3\u7530\u3000\u76f4\uff1aCOVID-19\u6d41\u884c\u4e0b\u306b\u304a\u3051\u308b\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642.\u7b2c252\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u95a2\u6771\u5730\u65b9\u4f1a.2022.11.5.\u6771\u4eac<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                          \n
                                                                          \n

                                                                          2021\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                          \n
                                                                          \n
                                                                          \n

                                                                          \u56fd\u5185\u7dcf\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                          \n
                                                                          \n

                                                                          \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                                            \n
                                                                          1. \u795e\u6238\u5bdb\u53f2\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u6642\u5ca1\u53f2\u660e\u3001\u4e39\u7fbd\u3000\u5d07\u3001\u77f3\u7530\u3000\u76f4\uff1a\u6210\u4ebaT\u7d30\u80de\u6027\u767d\u8840\u75c5\u306e\u540c\u7a2e\u9020\u8840\u7d30\u80de\u79fb\u690d\u5f8c\u306b\u767a\u75c7\u3057\u305f\u6025\u6027\u80baGVHD\u3092\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067\u8a3a\u65ad\u3057\u305f\u4e00\u4f8b.\u7b2c61\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2021.4.23.WEB<\/li>\n\n\n\n
                                                                          2. \u672c\u5009\u512a\u7f8e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5ddd\u7027\u6b63\u5178\u3001\u7532\u7530\u62d3\u4e4b\u3001\u767e\u702c\u3000\u5321\u3001\u4e2d\u897f\u967d\u7950\u3001\u6ff1\u5ddd\u6b63\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u3067\u306eIgG4\u95a2\u9023\u547c\u5438\u5668\u75be\u60a3\u306b\u304a\u3051\u308b\u81e8\u5e8a\u7684\u7279\u5fb4\u306e\u691c\u8a0e.\u7b2c61\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2021\/4\/23.WEB<\/li>\n\n\n\n
                                                                          3. \u6a2a\u5c71\u4fca\u79c0\u3001\u798f\u7530\u3000\u6cf0\u3001\u85e4\u5ddd\u3000\u6842\u3001\u9234\u6728\u79c0\u548c\u3001\u4e0a\u6d6a\u3000\u5065\u3000\u4ed6\uff1aStage \u2163\u671fEGFR\u967d\u6027NSCLC\u306b\u5bfe\u3059\u308bEGFR-TKI\u306e\u6cbb\u7642\u6210\u7e3e\u3068T790M\u691c\u51fa\u306e\u691c\u8a0e\uff1aHOPE002.\u7b2c61\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2021.4.23.WEB<\/li>\n\n\n\n
                                                                          4. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\uff1aCommunity-onset pueumonia\u3000\u306b\u304a\u3051\u308b\u8aa4\u56a5\u6027\u80ba\u708e\u3068\u975e\u8aa4\u56a5\u6027\u80ba\u708e\u306e\u6bd4\u8f03\u691c\u8a0e.\u7b2c61\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2021.4.25.WEB<\/li>\n\n\n\n
                                                                          5. \u6a2a\u6c5f\u771f\u5f25\u3001\u6a2a\u5c71 \u4fca\u79c0, \u6ff1\u5ddd \u6b63\u5149, \u798f\u7530 \u6cf0, \u77f3\u7530 \u76f4\uff1adurvalumab\u3092\u6295\u4e0e\u3057\u305fIII\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u75c7\u4f8b\u306b\u304a\u3051\u308b\u653e\u5c04\u7dda\u80ba\u81d3\u708e\u306b\u3064\u3044\u3066\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c61\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2021.4.25.WEB<\/li>\n\n\n\n
                                                                          6. \u4e2d\u897f\u967d\u7950\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u672c\u5009\u512a\u7f8e\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u5ddd\u7027\u6b63\u5178\u3001\u767e\u702c\u3000\u5321\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u6c17\u7ba1\u652f\u93e1\u691c\u67fb\u3067\u78ba\u5b9a\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u80baMycobacterium avium complex\u75c7\u60a3\u8005\u306e\u80cc\u666f\u3068\u691c\u67fb\u624b\u6cd5\u306e\u691c\u8a0e.\u7b2c44\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.6.24.WEB<\/li>\n\n\n\n
                                                                          7. \u795e\u6238 \u5bdb\u53f2\u3001\u6709\u7530 \u771f\u77e5\u5b50, \u4e39\u7fbd \u5d07, \u6642\u5ca1 \u53f2\u660e, \u77f3\u7530 \u76f4\uff1a\u6025\u6027\u767a\u75c7\u3057\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u95a2\u9023\u9593\u8cea\u6027\u80ba\u75be\u60a3(Acute onset Systemic Lupus Erythematosus Interstitial Lung Disease).\u7b2c44\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.6.24.WEB<\/li>\n\n\n\n
                                                                          8. \u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5ddd\u7027\u6b63\u5178\u3001\u7532\u7530\u62d3\u4e4b\u3001\u767e\u702c\u3000\u5321\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u5598\u606f\u5408\u4f75\u6162\u6027\u597d\u9178\u7403\u6027\u80ba\u708e\u306b\u5bfe\u3057\u3066\u751f\u7269\u5b66\u7684\u88fd\u5264\u306b\u3066\u6cbb\u7642\u3092\u884c\u3063\u305f8\u4f8b.\u7b2c70\u56de\u65e5\u672c\u30a2\u30ec\u30eb\u30ae\u30fc\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a.2021.10.9.WEB<\/li>\n\n\n\n
                                                                          9. \u6642\u5ca1\u53f2\u660e\u3001\u5869\u6d25\u662d\u5b50\u3001\u6a4b\u672c\u3000\u5fb9\uff1a\u753b\u50cf\u8a3a\u65ad\u30ec\u30dd\u30fc\u30c8\u78ba\u8a8d\u306e\u30cc\u30b1\u30e2\u30ec\u306a\u3044\u30b7\u30b9\u30c6\u30e0\u306e\u69cb\u7bc9\uff5e\u300e\u672a\u8aad\u9632\u6b62\u300f\u3068\u300e\u5371\u6a5f\u7684\u6240\u898b\u5bfe\u5fdc\u300f\u3068\u300e\u672a\u5bfe\u5fdc\u9632\u6b62\u306e3\u30b7\u30b9\u30c6\u30e0\uff5e\u300f.\u7b2c16\u56de\u533b\u7642\u306e\u8cea\u30fb\u5b89\u5168\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.11.27.WEB<\/li>\n\n\n\n
                                                                          10. \u798f\u7530\u3000\u6cf0\u3001\u6797\u3000\u79c0\u654f\u3001\u83c5\u539f\u4fca\u4e00\u3001\u4f50\u85e4\u60a0\u57ce\u3001\u4ed6\uff1a\u8010\u6027\u5316\u3057\u305fEGFR\u907a\u4f1d\u5b50\u5909\u7570\u967d\u6027\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308bNIVOLUMAB\u3068CBDCA+PEM\u306e\u7b2c2\u76f8\u6bd4\u8f03\u81e8\u5e8a\u8a66\u9a13\uff08WJOG8515L\uff09.\u7b2c62\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.11.28.WEB<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                                            \n

                                                                            \u7279\u5225\u8b1b\u6f14<\/p>\n\n\n\n

                                                                              \n
                                                                            1. \uff1c\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff1e\u4f0a\u85e4\u660e\u5e83\uff1aWith\u3000\u30b3\u30ed\u30ca\u6642\u4ee3\u306e\u547c\u5438\u5668\u611f\u67d3\u75c7\u8a3a\u7642\u306b\u304a\u3051\u308b\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u3092\u8003\u3048\u308b\uff0dCOVID-19\u8a3a\u7642\u306b\u304a\u3051\u308b\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u6e2c\u5b9a\u306e\u610f\u7fa9\u3092\u4e2d\u5fc3\u306b\uff0d.\u7b2c61\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2021.4.23.WEB<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                              \n
                                                                              \n

                                                                              \u56fd\u5185\u5730\u65b9\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                              \n
                                                                              \n

                                                                              \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                                                \n
                                                                              1. \u795e\u6238\u5bdb\u53f2\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6885\u7530\u6b66\u82f1\u3001\u77f3\u7530\u3000\u76f4\uff1aNivolumab48\u30b3\u30fc\u30b9\u6295\u4e0e\u5f8c\u306b\u767a\u75c7\u3057\u305f\u8457\u540d\u306a\u53e3\u6e07\u3068\u91cd\u75c7\u4f4e\u30ca\u30c8\u30ea\u30a6\u30e0\u8840\u75c7\u3092\u5408\u4f75\u3057\u305f\u553e\u6db2\u817a\u708e\u306e\u4e00\u4f8b.\u7b2c59\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u652f\u90e8\u5b66\u8853\u5927\u4f1a.2021.8.7.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                              2. \u672c\u5009\u512a\u7f8e\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5ddd\u7027\u6b63\u5178\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u7532\u7530\u62d3\u4e4b\u3001\u767e\u702c\u3000\u5321\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u80ba\u30af\u30ea\u30d7\u30c8\u30b3\u30c3\u30af\u30b9\u75c7\u306e\u4e00\u4f8b.\u7b2c63\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.8.7.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                              3. \u6a2a\u5c71\u4fca\u79c0\uff1aALK\u967d\u6027\u80ba\u304c\u3093\u306e\u6700\u8fd1\u306e\u6cbb\u7642\u6226\u7565.\u7b2c59\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u652f\u90e8\u5b66\u8853\u5927\u4f1a.2021.8.8.\u5ca1\u5c71<\/li>\n\n\n\n
                                                                              4. \u5ddd\u7027\u6b63\u5178\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u77f3\u7530\u3000\u76f4\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u767e\u702c\u3000\u5321\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\uff1aFilmArray\u547c\u5438\u5668\u30d1\u30cd\u30eb\u3067\u8a3a\u65ad\u3057\u305f\u5065\u5e38\u6210\u4eba\u306eCoronavirusOC43\u306b\u3088\u308b\u80ba\u708e\u306e\u4e00\u4f8b.\u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.11.5.\u5c90\u961c<\/li>\n\n\n\n
                                                                              5. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u672c\u5009\u512a\u7f8e\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\uff1a\u5c3f\u4e2d\u6297\u539f\u691c\u67fb\u306e\u518d\u691c\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e4\u4f8b\u306e\u691c\u8a0e.\u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.11.5.\u5c90\u961c<\/li>\n\n\n\n
                                                                              6. \u672c\u5009\u512a\u7f8e\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u672c\u5009\u512a\u7f8e\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u3000\u771f\u77e5\u5b50\uff1a\u30ea\u30dc\u30c6\u30b9\u30c8\u30ec\u30b8\u30aa\u30cd\u30e9\u306e\u7d4c\u6642\u7684\u6e2c\u5b9a\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u91cd\u75c7\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u306e1\u4f8b.2021.11.5.\u5c90\u961c<\/li>\n\n\n\n
                                                                              7. \u4e2d\u897f\u967d\u7950\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u7530\u4e2d\u5f69\u52a0\uff1a\u56fa\u5f62\u764c\u5316\u5b66\u7642\u6cd5\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6c17\u7ba1\u652f\u80ba\u80de\u6d17\u6d44\u6db2\u3067Pneumocystis jirovecii-PCR\u967d\u6027\u3068\u306a\u3063\u305f\u75c7\u4f8b\u306b\u304a\u3051\u308b\u5f8c\u65b9\u7684\u691c\u8a0e.2021.11.6.\u5c90\u961c<\/li>\n\n\n\n
                                                                              8. \u795e\u6238\u5bdb\u53f2\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\uff1aCOVID-1\u306b\u3088\u308b\u591a\u7cfb\u7d71\u708e\u75c7\u6027\u75c7\u5019\u7fa4\u3001\u91cd\u75c7\u4e0b\u80a2\u865a\u8840\u3092\u767a\u75c7\u3057\u305f1\u4f8b.\u7b2c125\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e2d\u56fd\u5730\u65b9\u4f1a.2021.11.6.WEB<\/li>\n\n\n\n
                                                                              9. \u5bae\ufa11\u7531\u4f9d\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u9f4b\u85e4\u5065\u8cb4\u3001\u4e2d\u897f\u967d\u7950\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u4f0a\u85e4\u3000\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u30a2\u30c6\u30be\u30ea\u30ba\u30de\u30d6\u6295\u4e0e\u4e2d\u306b\u8840\u7403\u8ca7\u98df\u75c7\u5019\u7fa4\u3092\u767a\u75c7\u3057\u305f\u80ba\u817a\u764c\u306e1\u4f8b.\u7b2c65\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.12.4.\u677e\u6c5f<\/li>\n\n\n\n
                                                                              10. \u5929\u91ce\u660e\u5f66\u3001\u4e2d\u897f\u967d\u7950\u3001\u6d5c\u677e\u572d\u592a\u3001\u798f\u7530\u3000\u6cf0\u3001\u77f3\u7530\u3000\u76f4\uff1a\u8457\u540d\u306a\u4f4e\u30ab\u30ea\u30a6\u30e0\u8840\u75c7\u3092\u5448\u3057\u305f\u7570\u6240\u6027ACTH\u7523\u751f\u80ba\u5c0f\u7d30\u80de\u764c\u306e\u4e00\u4f8b.\u7b2c65\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.12.4.\u677e\u6c5f<\/li>\n\n\n\n
                                                                              11. \u795e\u6238\u5bdb\u53f2\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u3000\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u7b2c4\u6ce2COVID-19\u60a3\u8005\u3078\u306e\u6cbb\u7642\u30ec\u30b8\u30e1\u30f3\u3068\u5b89\u5168\u6027\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e.\u7b2c65\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.12.4.\u677e\u6c5f<\/li>\n\n\n\n
                                                                              12. \u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u6a4b\u672c\u3000\u5fb9\u3001\u767e\u702c\u3000\u5321\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u3000\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\uff1a75\u6b73\u4ee5\u4e0a\u306e\u9ad8\u9f62\u80baMAC\u75c7\u60a3\u8005\u306b\u304a\u3051\u308b\u6cbb\u7642\u306e\u6709\u52b9\u6027\u3068\u5b89\u5168\u6027\u306e\u691c\u8a0e\uff5e\u524d\u5411\u304d\u30b3\u30db\u30fc\u30c8\u30c7\u30fc\u30bf\u304b\u3089\u306e\u89e3\u6790\uff5e.\u7b2c72\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u652f\u90e8\u4f1a.2021.12.5.\u677e\u6c5f<\/li>\n\n\n\n
                                                                              13. \u767e\u702c\u3000\u5321\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u672c\u5009\u512a\u7f8e\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5ddd\u7027\u6b63\u5178\u3001\u7532\u7530\u62d3\u4e4b\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u4e2d\u897f\u967d\u7950\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u4e2d\u306bMTX-LPD\u304c\u7591\u308f\u308c\u305f\u80ba\u7d50\u6838\u3001\u6c17\u7ba1\u652f\u7d50\u6838\u3001\u7d50\u6838\u6027\u30ea\u30f3\u30d1\u7bc0\u708e\u306e1\u4f8b.\u7b2c72\u56de\u65e5\u672c\u7d50\u6838\u30fb\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u652f\u90e8\u4f1a.2021.12.5.\u677e\u6c5f<\/li>\n\n\n\n
                                                                              14. \u7532\u7530\u62d3\u4e4b\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u77f3\u7530\u3000\u76f4\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5ddd\u7027\u6b63\u5178\u3001\u65e9\u702c\u767e\u3005\u5b50\u3001\u767e\u702c\u3000\u5321\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\uff1a\u7e70\u308a\u8fd4\u3059\u30ec\u30b8\u30aa\u30cd\u30e9\u691c\u67fb\u306b\u3088\u308a\u3001\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u3068\u8a3a\u65ad\u3067\u304d\u305f1\u4f8b.\u7b2c65\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.12.5.\u677e\u6c5f<\/li>\n<\/ol>\n<\/div>\n\n\n\n
                                                                                \n

                                                                                \u7279\u5225\u8b1b\u6f14<\/p>\n\n\n\n

                                                                                  \n
                                                                                1. \uff1c\u5f8c\u671f\u7814\u4fee\u533b\u30bb\u30c3\u30b7\u30e7\u30f3\uff1e\u795e\u6238\u5bdb\u53f2\uff1aSeminal vesiculitis due to methicillin-resistant Staphylococcus aureus in an immuno-compromised host.\u7b2c91\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.11.5.\u5c90\u961c<\/li>\n\n\n\n
                                                                                2. \uff1c\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff1e\u4f0a\u85e4\u3000\u660e\u5e83\uff1a\u80baMAC\u6240\u6cbb\u7642\u306e\u8ab2\u984c\u3068\u3053\u308c\u304b\u3089\u3092\u8003\u3048\u308b\uff5e\u30a2\u30ea\u30b1\u30a4\u30b9\u5438\u5165\u6cbb\u7642\u306b\u671f\u5f85\u3055\u308c\u308b\u5f79\u5272\u3068\u306f\uff5e.\u7b2c72\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2021.12.4.\u677e\u6c5f<\/li>\n\n\n\n
                                                                                3. <\u7279\u5225\u8b1b\u6f14\uff1e\u798f\u7530\u3000\u6cf0\u3001\u9032\u5c55\u578b\u5c0f\u7d30\u80de\u80ba\u764c\u3078\u306e\u8907\u5408\u514d\u75ab\u7642\u6cd5\u3000U\uff50date.\u7b2c65\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.12.4.\u677e\u6c5f<\/li>\n\n\n\n
                                                                                4. \uff3b\u30b9\u30dd\u30f3\u30b5\u30fc\u30c9\u30bb\u30df\u30ca\u30fc\uff3d\u798f\u7530\u3000\u6cf0\uff1a\u5b9f\u81e8\u5e8a\u306b\u304a\u3051\u308bIPI+NIVO\u00b1Chemo\u306e\u4f7f\u7528\u7d4c\u9a13.\u7b2c65\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.2021.12.5.\u677e\u6c5f<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                                  \n
                                                                                  \n

                                                                                  2020\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                  \n
                                                                                  \n
                                                                                  \n

                                                                                  \u56fd\u969b\u5b66\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                  \n
                                                                                    \n
                                                                                  1. Yokoyama \uff34,Yoshioka \uff28,Harada \uff24, Kozuki \uff34,et al\uff1aA Phase \u2161 Tria of Alectinib-Refractory Non-Small Lumg Cancer with EML5-ALK Fusion Genes;\u3000Okayama Lung Cancer Study Group 1405.\uff1aASCO Annual Meeting. 2020.5.29.\uff37\uff25\uff22.<\/li>\n\n\n\n
                                                                                  2. Yosuke N, Ito A, Ishida T, Tachibana H, Mitui M: Comparative prospective cohort of the efficacy and safety according to doses of Ceftriaxone in community-acquired pneumonia.ERS2020.WEB.<\/li>\n\n\n\n
                                                                                  3. Yokoe s, Ito A, Tachibana H, Mitui M, Nakanishi Y, Ishida T: New prediction score without subjective parameters for community-acquired Legionella pneumonia.ERS2020.WEB.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                    \n
                                                                                    \n

                                                                                    \u56fd\u5185\u7dcf\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                    \n

                                                                                    \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                                                      \n
                                                                                    1. \u4e2d\u897f\u967d\u7950\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e09\u30c4\u4e95\u7f8e\u7a42\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5c71\u5f62\u6602\u3001\u767e\u702c\u5321\u3001\u7530\u4e2d\u53cb\u6a39\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u798f\u7530\u6cf0\u3001\u4e39\u7fbd\u5d07\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u76f4\uff1a\u6c17\u7ba1\u652f\u5185\u8996\u93e1\u691c\u67fb\u3067\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u80ba\u653e\u7dda\u83cc\u75c711\u4f8b\u306e\u691c\u8a0e. \u7b2c43\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u7d19\u4e0a\u958b\u50ac\uff09.2020.6.26-27.<\/li>\n\n\n\n
                                                                                    2. \u6a2a\u6c5f\u771f\u5f25\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e09\u30c4\u4e95\u7f8e\u7a42\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u5c71\u5f62\u6602\u3001\u767e\u702c\u5321\u3001\u7530\u4e2d\u53cb\u6a39\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u798f\u7530\u6cf0\u3001\u4e39\u7fbd\u5d07\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u751f\u691c\u3067\u7d0438\u339c\u5927\u306e\u7d44\u7e54\u3092\u5f97\u305f\u3053\u3068\u3067\u6b63\u78ba\u306a\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u6df7\u5408\u578b\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u4e00\u4f8b. \u7b2c43\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u7d19\u4e0a\u958b\u50ac\uff09.2020.6.26-27.<\/li>\n\n\n\n
                                                                                    3. \u767e\u702c\u5321\u3001\u4e39\u7fbd\u5d07\u3001\u4e2d\u897f\u967d\u7950\u3001\u798f\u7530\u6cf0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u5f8c\u306b\u611f\u67d3\u3092\u8d77\u3053\u3057\u305f2\u75c7\u4f8b. \u7b2c43\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u7d19\u4e0a\u958b\u50ac\uff09.2020.6.26-27.<\/li>\n\n\n\n
                                                                                    4. \u795e\u6238\u5bdb\u53f2\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6a2a\u6c5f\u771f\u5f25\u3001\u767e\u702c\u5321\u3001\u5c71\u5f62\u6602\u3001\u7530\u4e2d\u53cb\u6a39\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u76f4\uff1a\u53f3\u4e2d\u8449\u306b\u5b64\u7acb\u7d50\u7bc0\u3092\u8a8d\u3081\u6c17\u7ba1\u652f\u93e1\u691c\u67fb\u3067\u78ba\u5b9a\u8a3a\u65ad\u304c\u5f97\u3089\u308c\u305f\u3001MMF\u8d77\u56e0\u6027\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b. \u7b2c43\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u7d19\u4e0a\u958b\u50ac\uff09.2020.6.26-27.<\/li>\n\n\n\n
                                                                                    5. \u795e\u6238\u5bdb\u53f2\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u5f37\u76ae\u75c7\u95a2\u9023\u9593\u8cea\u6027\u80ba\u708e\u306b\u5bfe\u3057\u3066\u85ac\u7269\u6cbb\u7642\u5c0e\u5165\u4f8b\u306e\u81e8\u5e8a\u7d4c\u904e\u306b\u95a2\u3059\u308b\u691c\u8a0e.\u7b2c60\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\uff37\uff25\uff22\uff092020.9.20-22.<\/li>\n\n\n\n
                                                                                    6. \u6a2a\u6c5f\u771f\u5f25\u3010\u7814\u4fee\u533b\u30c8\u30e9\u30d9\u30eb\u30a2\u30ef\u30fc\u30c9\u53d7\u8cde\u3011\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u77f3\u7530\u76f4\uff1a\u5e02\u4e2d\u80ba\u708e\u306b\u304a\u3051\u308b\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u8a3a\u65ad\u30b9\u30b3\u30a2\u306e\u4f5c\u6210\u3068\u8a3a\u65ad\u80fd\u306e\u691c\u8a0e\u3000\u5f53\u9662\u306e\u524d\u5411\u304d\u30b3\u30db\u30fc\u30c8\u30c7\u30fc\u30bf\u306e\u89e3\u6790.\u7b2c60\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\uff37\uff25\uff22\uff092020.9.20-22.<\/li>\n\n\n\n
                                                                                    7. \u767e\u702c\u5321\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4e39\u7fbd\u5d07\u3001\u798f\u7530\u6cf0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6885\u7530\u6b66\u82f1\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3068\u7d4c\u6c17\u7ba1\u652f\u751f\u691c\u306e\u5408\u4f75\u75c7\u306e\u691c\u8a0e.\u7b2c60\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\uff08\uff37\uff25\uff22\uff09.2020.9.20.<\/li>\n\n\n\n
                                                                                    8. \u4e09\u30c4\u4e95\u7f8e\u7a42\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u4e2d\u897f\u967d\u7950\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u76f4\uff1a\u5f53\u9662\u5e02\u4e2d\u767a\u75c7\u80ba\u708e\u5165\u9662\u60a3\u8005\u3067\u306e\u30cf\u30a4\u30d5\u30ed\u30fc\u30cd\u30fc\u30b6\u30eb\u30ab\u30cb\u30e5\u30fc\u30e9\u306e\u4f7f\u7528\u72b6\u6cc1\u3068\u8ee2\u5e30\u306b\u3064\u3044\u3066\uff5e\u524d\u5411\u304d\u30b3\u30db\u30fc\u30c8\u30c7\u30fc\u30bf\u306e\u89e3\u6790\uff5e.\u7b2c42\u56de\u65e5\u672c\u547c\u5438\u7642\u6cd5\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.2020.12.20.\u4eac\u90fd.<\/li>\n\n\n\n
                                                                                    9. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u76f4\uff1a\u80ba\u708e\u306e\u6cbb\u7642\u306f\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304b\u30b0\u30e9\u30e0\u67d3\u8272\u30d9\u30fc\u30b9\u304b\uff1f. \u7b2c42\u56de\u65e5\u672c\u547c\u5438\u7642\u6cd5\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.2020.12.21.\u4eac\u90fd.<\/li>\n\n\n\n
                                                                                    10. \u798f\u7530\u6cf0\u3001\u767e\u702c\u5321\u3001\u4e2d\u897f\u967d\u7950\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6709\u7530\u771e\u77e5\u5b50\u3001\u77f3\u7530\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308b\u9ad8\u9f62\u8005\u306b\u5bfe\u3057\u3066\u306e\uff30\uff45\uff4d\uff42\uff52\uff4f\uff4c\uff49\uff5a\uff55\uff4d\uff41\uff42\u3068\u5316\u5b66\u7642\u6cd5\u306e\u4f75\u7528\u7642\u6cd5\u306b\u95a2\u3057\u3066. \u7b2c61\u56de\u65e5\u672c\u80ba\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.2020.11.12.\u5ca1\u5c71.<\/li>\n<\/ol>\n\n\n\n

                                                                                      \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/p>\n\n\n\n

                                                                                        \n
                                                                                      1. \u4f0a\u85e4\u660e\u5e83. \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u5bfe\u7b56\uff5e\u3069\u3053\u307e\u3067\u3084\u3063\u305f\u3089\u5b89\u5168\uff1f\u5b89\u5fc3\uff1f\uff5e \u6297\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u85ac\u8010\u6027\u306e\u52d5\u5411\u3068\u4eca\u5f8c\u306e\u6cbb\u7642. \u7b2c35\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a. 2020.2.14-15.\u6a2a\u6d5c.<\/li>\n\n\n\n
                                                                                      2. \u77f3\u7530 \u76f4\uff1a\uff1c\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3\uff1e\u6297\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u85ac\u306e\u9069\u6b63\u4f7f\u7528\u3092\u8003\u3048\u308b\uff1a\u547c\u5438\u5668\u5185\u79d1\u533b\u306e\u7acb\u5834\u304b\u3089. \u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u7dcf\u4f1a.2020.912-14.\u795e\u6238.<\/li>\n<\/ol>\n\n\n\n

                                                                                        \u7279\u5225\u8b1b\u6f14<\/p>\n\n\n\n

                                                                                          \n
                                                                                        1. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u76f4\uff1a\u3010\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u8b1b\u6f14\u3011\u8aa4\u56a5\u6027\u80ba\u708e\u3092\u7406\u89e3\u3059\u308b. \u7b2c42\u56de\u65e5\u672c\u547c\u5438\u7642\u6cd5\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.2020.12.21.\u4eac\u90fd.<\/li>\n\n\n\n
                                                                                        2. \u4f0a\u85e4\u660e\u5e83\uff1a\uff1c\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc\uff1eWith \u30b3\u30ed\u30ca\u6642\u4ee3\u306e\u547c\u5438\u5668\u611f\u67d3\u75c7\u8a3a\u7642\u306b\u304a\u3051\u308b\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u6e2c\u5b9a\u306e\u5f79\u5272\uff5e\u30d7\u30ed\u30ab\u30eb\u30b7\u30c8\u30cb\u30f3\u7d4c\u6642\u7684\u6e2c\u5b9a\u306e\u91cd\u8981\u6027\uff5e\u7b2c42\u56de\u65e5\u672c\u547c\u5438\u7642\u6cd5\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.2020.12.21.\u4eac\u90fd.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                          \n
                                                                                          \n

                                                                                          \u56fd\u5185\u5b66\u4f1a\u30fb\u5730\u65b9\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                          \n

                                                                                          \u4e00\u822c\u6f14\u984c<\/p>\n\n\n\n

                                                                                            \n
                                                                                          1. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u6642\u5ca1\u53f2\u660e\uff1a\u80ba\u708e\u7403\u83cc\u5c3f\u4e2d\u6297\u539f\u8fc5\u901f\u8a3a\u65ad\u967d\u6027\u5e02\u4e2d\u80ba\u708e\u60a3\u8005\u306b\u304a\u3051\u308b\u6297\u83cc\u85ac\u6cbb\u7642\u306e\u5b9f\u614b\uff5e\u6a19\u7684\u6cbb\u7642\u9078\u629e\u306e\u8981\u56e0\u306e\u691c\u8a0e\uff5e.\u7b2c68\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a.2020.11.5-17.\u798f\u5ca1.<\/li>\n\n\n\n
                                                                                          2. \u4f0a\u85e4\u660e\u5e83\u3001\u77f3\u7530\u3000\u76f4\u3001\u4e2d\u897f\u967d\u7950\u3001\u7530\u4e2d\u5f69\u52a0\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\uff1a\u80ba\u708e\u7403\u83cc\u80ba\u708e\u8a3a\u65ad\u306b\u304a\u3051\u308b\u5165\u4e2d\u6297\u539f\u8fc5\u901f\u8a3a\u65ad\u30ad\u30c3\u30c8\u300cBinaxNOW \u80ba\u708e\u7403\u83cc\u300d\u306e\u611f\u5ea6\u306e\u7d4c\u6642\u7684\u63a8\u79fb\u306b\u3064\u3044\u3066.\u7b2c90\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a.\u798f\u5ca1.<\/li>\n\n\n\n
                                                                                          3. \u6a2a\u6c5f\u771f\u5f25\u3001\u6a2a\u5c71\u4fca\u79c0\u3001\u672c\u5009\u512a\u7f8e\u3001\u6817\u5ca1\u52c7\u8f14\u3001\u5ddd\u7027\u6b63\u5178\u3001\u7532\u7530\u62d3\u4e4b\u3001\u767e\u702c\u3000\u5321\u3001\u4e2d\u897f\u967d\u7950\u3001\u6ff1\u5ddd\u6b63\u5149\u3001\u798f\u7530\u3000\u6cf0\u3001\u4f0a\u85e4\u660e\u5e83\u3001\u6642\u5ca1\u53f2\u660e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u77f3\u7530\u3000\u76f4\uff1a\u975e\u533a\u57df\u6027\u6d78\u6f64\u5f71\u3092\u5448\u3057\u305f\u80ba\u817a\u764c\u306b\u30af\u30e9\u30a4\u30aa\u751f\u691c\u3092\u65bd\u884c\u3057\u305f\u3053\u3068\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u4e00\u4f8b.\u7b2c64\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff08\uff37\uff25\uff22\uff09.2020.11.21.<\/li>\n\n\n\n
                                                                                          4. \u672c\u5009\u512a\u7f8e\u3001\u6709\u7530\u771f\u77e5\u5b50\u3001\u6817\u5ca1\u52c7\u8f14\u3001\u6642\u5ca1\u53f2\u660e\u3001\u77f3\u7530\u3000\u76f4\u3001\u59c9\u5ddd\u4fee\u5b50\u3001\u5409\u7530\u77e5\u5b8f\u3001\u8107\u3000\u5927\u8f14\u3001\u897f\u6751\u5553\u4f51\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067\u8a3a\u65ad\u306b\u81f3\u3063\u305f\u80ba\u75c5\u5909\u3067\u518d\u71c3\u3057\u305f\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\u306e\u4e00\u4f8b. \u7b2c64\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff08\uff37\uff25\uff22\uff09.2020.11.21.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                                            \n

                                                                                            \u7814\u7a76\u4f1a\u30fb\u8b1b\u6f14\u4f1a<\/h4>\n\n\n\n
                                                                                            \n
                                                                                            \n

                                                                                            2024\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                            \n
                                                                                            \n
                                                                                            \n

                                                                                            \u7814\u7a76\u4f1a\u30fb\u52c9\u5f37\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                            \n
                                                                                              \n
                                                                                            1. \u677e\u4e95\u99a8\u5b50\uff1a\u80ba\u80de\u51fa\u8840\u3067\u767a\u75c7\u3057\u305f\u3001\u30d7\u30ed\u30d4\u30eb\u30c1\u30aa\u30a6\u30e9\u30b7\u30eb\u306b\u3088\u308b\u85ac\u5264\u6027\u8a98\u767a\u6027ANCA\u95a2\u8840\u7ba1\u708e\u306e1\u4f8b.\u7b2c64\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a.2024.6.7.\u5009\u6577<\/li>\n\n\n\n
                                                                                            2. \u9ad9\u6a4b\u3000\u5bdb\uff1a\u591a\u5f69\u306a\u80ba\u75c5\u5909\u304c\u518d\u767a\u6027\u591a\u767a\u6027\u8edf\u9aa8\u708e\u3068\u306e\u9451\u5225\u306b\u6709\u7528\u3067\u3042\u3063\u305fVEXAS\u75c7\u5019\u7fa4\u306e1\u4f8b. \u7b2c64\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a.2024.6.7.\u5009\u6577<\/li>\n\n\n\n
                                                                                            3. \u9ad9\u6a4b\u3000\u5bdb\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u304c\u8a3a\u65ad\u306b\u5bc4\u4e0e\u3057\u305f\u3001\u3073\u307e\u3093\u6027\u30b9\u30ea\u30ac\u30e9\u30b9\u9670\u5f71\u306e1\u4f8b. \u7b2c38\u56de\u795e\u6238\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2024.6.22.\u795e\u6238<\/li>\n\n\n\n
                                                                                            4. \u5929\u91ce\u660e\u5f66\uff1a\u4e9c\u6025\u6027\u306b\u9032\u884c\u3059\u308b\u3073\u6162\u6027\u306e\u30b9\u30ea\u30ac\u30e9\u30b9\u5f71\u3001\u73ed\u72b6\u5f71\u3092\u8a8d\u3081\u305f1\u4f8b. \u7b2c38\u56de\u795e\u6238\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2024.6.22.\u795e\u6238<\/li>\n\n\n\n
                                                                                            5. \u9ad9\u6a4b\u3000\u5bdb\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3092\u5b9f\u65bd\u3057\u305f\u3073\u307e\u3093\u6027\u30b9\u30ea\u30ac\u30e9\u30b9\u9670\u5f71\u306e1\u4f8b\uff0e\u7b2c39\u56de\u795e\u6238\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a\uff0e2024.11.9.\u795e\u6238\u3000<\/li>\n\n\n\n
                                                                                            6. \u5929\u91ce\u660e\u5f66\u3001\u6ff1\u5ddd\u6b63\u5149\uff1aANCA\u95a2\u9023\u8840\u7ba1\u708e\u306b\u4f34\u3046\u80ba\u75c5\u5909\u306e1\u4f8b\uff0e\u7b2c39\u56de\u795e\u6238\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a\uff0e2024.11.9.\u795e\u6238<\/li>\n\n\n\n
                                                                                            7. \u6ff5\u5c3e\u4fe1\u53d4\uff1aCOVID-19\u306b\u3064\u3044\u3066\uff0e\u7b2c65\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a\uff0e2024.11.19.\u5009\u6577<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                              \n
                                                                                              \n

                                                                                              \u8b1b\u6f14\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                              \n
                                                                                                \n
                                                                                              1. \u4f0a\u85e4\u660e\u5e83\uff1a\u65b0\u305f\u306a\u5c55\u958b\u3092\u8fce\u3048\u305f\u80ba\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7\u8a3a\u7642\uff5e\u5598\u606f\u30fbOCS\u5185\u670d\u3068\u306e\u95a2\u9023\u6027\u3092\u542b\u3081\uff5e. \u9cf4\u9580\u5e02\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2024.2.6.\u5fb3\u5cf6<\/li>\n\n\n\n
                                                                                              2. \u6ff1\u5ddd\u6b63\u5149\uff1a\u5730\u57df\u3067\u8003\u3048\u308b\u9593\u8cea\u6027\u80ba\u708e\u8a3a\u7642. \u7b2c470\u56de\u5009\u6577\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2024.3.12.\u5ca1\u5c71<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                \n
                                                                                                \n

                                                                                                2023\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                \n
                                                                                                \n
                                                                                                \n

                                                                                                \u7814\u7a76\u4f1a\u30fb\u52c9\u5f37\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                \n
                                                                                                  \n
                                                                                                1. \u5c71\u91ce\u9686\u53f2\uff1a.\u7e4a\u7dad\u5316\u306e\u9032\u884c\u3092\u8a8d\u3081\u305fIgG4\u95a2\u9023\u80ba\u75be\u60a3\u306e\u4e00\u4f8b\u7b2c36\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2023.5.13<\/li>\n\n\n\n
                                                                                                2. \u5c71\u91ce\u9686\u53f2\uff1a\u3073\u307e\u3093\u6027GGA\u3084\u6de1\u3044\u7c92\u72b6\u5f71\u3092\u8a8d\u3081\u305f\u9593\u8cea\u6027\u80ba\u708e\u306e\u4e00\u4f8b36\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2023.5.13<\/li>\n\n\n\n
                                                                                                3. \u798f\u7530\u3000\u6cf0\uff1a\u4fb5\u8972\u6027\u80ba\u708e\u7403\u83cc\u611f\u67d3\u75c7\u3092\u5408\u4f75\u3057\u305fCOVID-19\u306e\u4e00\u4f8b.\u7b2c62\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a.2023.6.27<\/li>\n\n\n\n
                                                                                                4. \u65e9\u702c\u3000\u767e\u3005\u5b50\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u30ef\u30af\u30c1\u30f3\u306b\u3088\u308b\u9593\u8cea\u6027\u80ba\u708e\u304c\u7591\u308f\u308c\u305f2\u75c7\u4f8b. \u7b2c62\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a.2023.6.27<\/li>\n\n\n\n
                                                                                                5. \u7530\u4e2d\u5f69\u52a0\uff1a\u4e0a\u8449PPFE\u69d8\u306e\u9670\u5f71\u3092\u5448\u3057\u305f\u9593\u8cea\u6027\u80ba\u708e\u306e\u4e00\u4f8b.\u7b2c37\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2023.10.14<\/li>\n\n\n\n
                                                                                                6. \u65e9\u702c\u767e\u3005\u5b50\uff1a\u691c\u8a3a\u3067\u7570\u5e38\u5f71\u3092\u6307\u6458\u3055\u308c\u305f\u9593\u8cea\u6027\u80ba\u708e\u306e\u4e00\u4f8b.\u7b2c37\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2023.10.14<\/li>\n\n\n\n
                                                                                                7. \u6ff1\u5ddd\u3000\u6b63\u5149\uff1a\u9593\u8cea\u6027\u80ba\u708e\u3000update\uff5e\u6700\u9069\u5316\u533b\u7642\u306b\u3080\u3051\u305f\u5f53\u9662\u306e\u53d6\u308a\u7d44\u307f\uff5e.\u7b2c63\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a.2023.12.8<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                  \n
                                                                                                  \n

                                                                                                  \u8b1b\u6f14\u4f1a<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                  \n
                                                                                                    \n
                                                                                                  1. \u77f3\u7530\u3000\u76f4\uff1a\u30c4\u30a4\u30f3\u30c7\u30df\u30c3\u30af\u4e0b\u306e\u547c\u5438\u5668\u611f\u67d3\u75c7\u8a3a\u7642.\u5ca9\u56fd\u5e02\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.1.18<\/li>\n\n\n\n
                                                                                                  2. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u305d\u3053\u306b\u3042\u308b\u80ba\u708e\uff1a\u9ad8\u9f62\u8005\u306f\u6c17\u3092\u3064\u3051\u3066.2023\u5e9c\u4e2d\u5730\u533a\u533b\u5e2b\u4f1a\u611f\u67d3\u75c7\u5bfe\u7b56\u7814\u4fee\u4f1a.2023.10.11.\u5e9c\u4e2d<\/li>\n\n\n\n
                                                                                                  3. \u6ff1\u5ddd\u6b63\u5149\uff1a\u5598\u606f\u6cbb\u7642update\uff5e\u6700\u9069\u5316\u533b\u7642\u306b\u5411\u3051\u305f\u5f53\u9662\u306e\u53d6\u308a\u7d44\u307f\uff5e. \u963f\u5357\u5b66\u8853\u8b1b\u6f14\u4f1a.2023.11.8<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                    \n
                                                                                                    \n

                                                                                                    2022\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                    \n
                                                                                                      \n
                                                                                                    1. \u4f0a\u85e4\u660e\u5e83\uff1a\u300c\u80baMAC\u75c7\u8a3a\u7642\u306e\u57fa\u672c\u304b\u3089\u6700\u65b0\u307e\u3067\u300d\uff5e\u5c02\u9580\u533b\u3068\u30d7\u30e9\u30a4\u30de\u30ea\u30b1\u30a2\u533b\u306b\u6c42\u3081\u3089\u308c\u308b\u5f79\u5272\u3068\u306f\uff5e.\u80baMAC\u75c7\u30bb\u30df\u30ca\u30fc in \u4f46\u99ac\/\u8c4a\u5ca1\u5e02\u533b\u5e2b\u4f1a.2022.6.1.\u8c4a\u5ca1<\/li>\n\n\n\n
                                                                                                    2. \u77f3\u7530\u3000\u76f4\uff1a\u8aa4\u56a5\u6027\u80ba\u708e\u3000up to date 2022.\u660e\u65e5\u304b\u3089\u5f79\u7acb\u3064\u80ba\u708e\u8a3a\u7642\u30bb\u30df\u30ca\u30fcin IBARAKI.2022.7.14WEB<\/li>\n\n\n\n
                                                                                                    3. \u77f3\u7530\u3000\u76f4\uff1aCOVID-19\u6642\u4ee3\u306e\u547c\u5438\u5668\u611f\u67d3\u75c7\u8a3a\u7642.\u6de1\u8def\u533b\u5e2b\u4f1aInfection Control Meeting.\u5357\u3042\u308f\u3058\u533b\u5e2b\u4f1a.2022.9.8.WEB<\/li>\n\n\n\n
                                                                                                    4. \u4f0a\u85e4\u660e\u5e83\uff1a\u80baMAC\u75c7\u306e\u9069\u5207\u306a\u7ba1\u7406\u3092\u8003\u3048\u308b~\u57fa\u672c\u304b\u3089\u6700\u65b0\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u307e\u3067\u3092\u3075\u307e\u3048\uff5e.\u5ca1\u5c71\u770c\u897f\u90e8\u5730\u533a\u3000\u80ba\uff2e\uff34\uff2d\u75c7\u6cbb\u7642\u9023\u643a\u306e\u4f1a.2022.10.14.\u5009\u6577<\/li>\n\n\n\n
                                                                                                    5. \u77f3\u7530\u3000\u76f4\uff1a\uff1c\u6559\u80b2\u8b1b\u6f14\uff1eCOVID-19\u6d41\u884c\u4e0b\u3067\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642.\u547c\u5438\u5668\u611f\u67d3\u75c7\u30ef\u30af\u30c1\u30f3\u7814\u7a76\u4f1a2022\/2022.10.22.\u6771\u4eac<\/li>\n\n\n\n
                                                                                                    6. \u4f0a\u85e4\u660e\u5e83\uff1a\u80baMAC\u75c7\u306b\u304a\u3051\u308b\u75c5\u75c5\u9023\u643a\u3001\u75c5\u8a3a\u9023\u643a\u3092\u8003\u3048\u308b\uff5e\u5f53\u9662\u306b\u304a\u3051\u308b\u80baMAC\u75c7\u306b\u5bfe\u3059\u308b\u53d6\u308a\u7d44\u307f\uff5e\u3001\u7b2c61\u56de\u897f\u90e8\u547c\u5438\u5668\u75be\u60a3\u61c7\u8a71\u4f1a.2022.12.23<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                      \n
                                                                                                      \n

                                                                                                      2021\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                      \n
                                                                                                        \n
                                                                                                      1. \u77f3\u7530\u3000\u76f4\uff1aCOVID-19 \u3053\u306e1\u5e74\u3092\u3075\u308a\u8fd4\u308b\u3000\u7d30\u83cc\u6027\u80ba\u708e\u5408\u4f75\u4f8b\u3082\u542b\u3081\u3066.\u7b2c99\u56de\u5009\u6577\u80f8\u90e8\u75be\u60a3\u61c7\u8a71\u4f1a.2021.8.25.\u5009\u6577<\/li>\n\n\n\n
                                                                                                      2. \u77f3\u7530\u3000\u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u5bfe\u7b56\u306e\u73fe\u72b6\u3068\u4eca\u5f8c\u306e\u5c55\u671b\u3000\u3053\u306e1\u5e74\u3092\u632f\u308a\u8fd4\u308b.2021\u5e74\u5c71\u53e3\u770c\u4fdd\u967a\u533b\u5354\u4f1a\u3000\u30b8\u30e7\u30a4\u30f3\u30c8\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9.2021.11.19.\u5c71\u53e3<\/li>\n\n\n\n
                                                                                                      3. \uff3b\u7279\u5225\u8b1b\u6f14\uff3d\u77f3\u7530\u3000\u76f4\uff1aCOVID-19\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u4e0b\u306b\u304a\u3051\u308b\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642.\u9999\u5ddd\u770c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\/\u9999\u5ddd\u770c\u85ac\u5264\u5e2b\u4f1a12\u6708\u5b9a\u4f8b\u7814\u4fee\u4f1a.2021.12.16.<\/li>\n\n\n\n
                                                                                                      4. \u65e9\u702c\u767e\u3005\u5b50\uff1a\u4e21\u80ba\u672b\u68a2\u306b\u591a\u767a\u3059\u308b\u80ba\u56a2\u80de\u306e\u4e00\u4f8b. \u7b2c33\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2021.12.\/4.WEB<\/li>\n\n\n\n
                                                                                                      5. \u5c71\u91ce\u9686\u53f2\uff1a\u4e21\u5074\u80ba\u91ce\u306b\u56a2\u80de\u3001\u7d50\u7bc0\u5f71\u3092\u4f34\u3046\u30b9\u30ea\u30ac\u30e9\u30b9\u5f71\u3092\u8a8d\u3081\u305f\u4e00\u4f8b. \u7b2c33\u56de\u3073\u307e\u3093\u6027\u80ba\u75be\u60a3\u52c9\u5f37\u4f1a.2021.12.4.WEB<\/li>\n\n\n\n
                                                                                                      6. \u77f3\u7530\u3000\u76f4\uff1a2021-2022\u5e74\u30b7\u30fc\u30ba\u30f3\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u3092\u4fef\u77b0\u3059\u308b.\u7b2c6\u56de\u5317\u4e5d\u5dde\u547c\u5438\u5668\u5b66\u4f1a.2021.11.25.WEB<\/li>\n\n\n\n
                                                                                                      7. \u77f3\u7530\u3000\u76f4\uff1a\u30b3\u30ed\u30ca\u798d\u3067\u306e\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u8a3a\u7642. \u7b2c2\u56de\u5c71\u5f62\u547c\u5438\u5668\u75be\u60a3\u7814\u7a76\u4f1a.2021.10.8.WEB<\/li>\n\n\n\n
                                                                                                      8. \u6642\u5ca1\u53f2\u660e\uff1a\u30c1\u30fc\u30e0\u3067\u53d6\u308a\u7d44\u3080\u91cd\u75c7\u5598\u606f\uff5e\u4e00\u4eba\u3067\u3082\u591a\u304f\u306e\u91cd\u75c7\u5598\u606f\u306e\u60a3\u8005\u3055\u3093\u3092\u6e1b\u3089\u3059\u305f\u3081\u306b\uff5e. \u5009\u6577\u547c\u5438\u5668\u30bb\u30df\u30ca\u30fc.2021.9.22.WEB<\/li>\n\n\n\n
                                                                                                      9. \uff3b\u7279\u5225\u8b1b\u6f14\uff3d\u4f0a\u85e4\u660e\u5e83.\u91cd\u75c7\u5598\u606f\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u6226\u7565\u3000with Covid-19\u3000\uff5e\u611f\u67d3\u75c7\u5c02\u9580\u533b\u304b\u3089\u306e\u8996\u70b9\uff5e. \u91cd\u75c7\u5598\u606f\u30bb\u30df\u30ca\u30fcin\u9ce5\u53d6.2021.9.1.WEB<\/li>\n\n\n\n
                                                                                                      10. \u77f3\u7530\u3000\u76f4\uff1aCOVID-19\u3000\u3053\u306e1\u5e74\u3092\u3075\u308a\u8fd4\u308b\u3000\u7d30\u83cc\u6027\u80ba\u708e\u5408\u4f75\u4f8b\u3082\u542b\u3081\u3066. \u7b2c99\u56de\u5009\u6577\u80f8\u90e8\u75be\u60a3\u61c7\u8a71\u4f1a.2021.8.25.\u5009\u6577<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                        \n
                                                                                                        \n

                                                                                                        2020\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                        \n
                                                                                                          \n
                                                                                                        1. \u77f3\u7530\u3000\u76f4\uff1a\u5e73\u6210\u306e\u80ba\u708e\u8a3a\u7642\u3092\u632f\u308a\u8fd4\u308b. \u304a\u304a\u3055\u304b\u547c\u5438\u5668\u30d5\u30a9\u30fc\u30e9\u30e0.2020.2.15.\u5927\u962a.<\/li>\n\n\n\n
                                                                                                        2. \u77f3\u7530\u3000\u76f4\uff1a\uff1c\u7279\u5225\u8b1b\u6f14\uff1e\u547c\u5438\u5668\u611f\u67d3\u75c7\u306e\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8. 2019\u5e74\u5ea6\u3000\u7b2c13\u56de\u3000\u5c71\u53e3\u770c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u8b1b\u6f14\u4f1a.2020.2.19.\u5c71\u53e3.<\/li>\n\n\n\n
                                                                                                        3. \u5c71\u5f62\u3000\u6602\u3001\u6709\u7530\u3000\u771e\u77e5\u5b50\uff0c\u6642\u5ca1\u53f2\u660e\uff0c\u77f3\u7530\u3000\u76f4\uff1a\u30af\u30e9\u30a4\u30aa\u30d0\u30a4\u30aa\u30d7\u30b7\u30fc\u3067\u8a3a\u65ad\u3057\u3048\u305f\u4e21\u80ba\u3073\u307e\u3093\u6027\u30b9\u30ea\u30ac\u30e9\u30b9\u5f71\u306e1\u4f8b. \u7b2c95\u56de\u5ca1\u5c71\u80f8\u90e8\u75be\u60a3\u61c7\u8a71\u4f1a.2020.2.25.\u5ca1\u5c71.<\/li>\n\n\n\n
                                                                                                        4. \u77f3\u7530\u3000\u76f4\uff1aCOVID-19\u306e\u73fe\u72b6\u3068\u5bfe\u7b56\uff1a\u8513\u5ef6\u671f\u306b\u5099\u3048\u3066. \u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a3\u30eb\u30b9\u5bfe\u7b56\u3000Web\u3000Live\u3000Seminar.2020.4.24.\u5ca1\u5c71.\u3000<\/li>\n\n\n\n
                                                                                                        5. \u77f3\u7530\u3000\u76f4\uff1a\u30ec\u30af\u30c1\u30e3\u30fc\u3000\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068COVID-19\u3078\u306e\u5bfe\u7b56. \u5009\u6577\u80f8\u90e8\u75be\u60a3\u61c7\u8a71\u4f1a.2020.8.26.\u5009\u6577.<\/li>\n\n\n\n
                                                                                                        6. \u77f3\u7530\u3000\u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a3\u30eb\u30b9\u611f\u67d3\u75c7\u3000\u6700\u65b0\u306e\u8a71\u984c\u3000\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\/\uff23\uff2f\uff36\uff29\uff24-19\u6d41\u884c\u306b\u5099\u3048\u3066. \u5ca1\u5c71\u770c\u4fdd\u967a\u533b\u5354\u4f1a\u3000\u6642\u5c40\u5bfe\u7b56\u8b1b\u6f14\u4f1a.2020.9.27.\u5ca1\u5c71.<\/li>\n\n\n\n
                                                                                                        7. \u6642\u5ca1\u53f2\u660e\uff1a\u5598\u606f\u8a3a\u7642\u306e\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb\uff5e\u305d\u306e\u5598\u606f\u306e\u8a3a\u65ad\u306f\u6b63\u3057\u3044\u3067\u3059\u304b\uff5e. \u5009\u6577\u5730\u533a\u5598\u606fForum.2020.10.2.\u5009\u6577.<\/li>\n\n\n\n
                                                                                                        8. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\/COVID19\u6d41\u884c\u306b\u5099\u3048\u3066. \u5c71\u53e3\u770c\u4fdd\u967a\u533b\u5354\u4f1a\u3000\u30b8\u30e7\u30a4\u30f3\u30c8\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9.2020.10.29.\u5c71\u53e3.<\/li>\n\n\n\n
                                                                                                        9. \u77f3\u7530\u3000\u76f4\uff1a\u5f53\u9662\u306b\u304a\u3051\u308bCOPD\u8a3a\u7642\u306e\u73fe\u72b6. COPD SUMMIT in \u5009\u6577\u3000episode2.2020.11.4.\u5009\u6577.<\/li>\n\n\n\n
                                                                                                        10. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068COVID-19\u306b\u5099\u3048\u3066. Influenza\u3000up to date Web Seminar.2020.11.9.\uff37\uff25\uff22.<\/li>\n\n\n\n
                                                                                                        11. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068\uff23\uff2f\uff36\uff29\uff24-19\u306b\u5099\u3048\u3066.\u59eb\u8def\u5e02\u533b\u5e2b\u4f1a.2020.11.14.\u59eb\u8def.<\/li>\n\n\n\n
                                                                                                        12. \u6709\u7530\u771f\u77e5\u5b50\uff1a\u9032\u5316\u3059\u308b\u9593\u8cea\u6027\u80ba\u708e\u6cbb\u7642\uff5e\u9032\u884c\u6027\u7dda\u7dad\u5316\u3092\u4f34\u3046\u9593\u8cea\u6027\u80ba\u75be\u60a3\u3068\u306f\uff5e.\uff30\uff26-\uff29\uff2c\uff24\u3000\uff37\uff25\uff42\u3000\uff21\uff43\uff41\uff44\uff45\uff4d\uff59.2020.11.55.\uff37\uff25\uff22.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                          \n

                                                                                                          \u53d6\u6750\u7b49<\/h4>\n\n\n\n
                                                                                                          \n
                                                                                                          \n

                                                                                                          2024\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                          \n
                                                                                                            \n
                                                                                                          1. \u77f3\u7530  \u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u3068\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3000\u533b\u7642\u6a5f\u95a2\u5f53\u305f\u308a\u60a3\u8005\u6570\u3000\u524d\u9031\u3088\u308a\u6e1b. NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.3.1<\/li>\n\n\n\n
                                                                                                          2. \u77f3\u7530 \u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u3000\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005\u6570\u6e1b\u5c11\u3082\u3000\u300c\u5f15\u304d\u7d9a\u304d\u5bfe\u7b56\u3092\u300d. NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.3.8<\/li>\n\n\n\n
                                                                                                          3. \u77f3\u7530 \u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u60a3\u8005\u65705\u7a2e\u9023\u7d9a\u6e1b\u5c11\u3000\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306f\u5897\u52a0\u306b\u8ee2\u3058\u308b. NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.3.15<\/li>\n\n\n\n
                                                                                                          4. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005\u6570 2\u9031\u9023\u7d9a\u5897\u52a0 \u65b0\u578b\u30b3\u30ed\u30ca\u306f6\u9031\u9023\u7d9a\u6e1b\u5c11.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8\uff1a2024.3.22<\/li>\n\n\n\n
                                                                                                          5. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005 4\u67087\u65e5\u307e\u30671\u9031\u9593 \u5168\u90fd\u9053\u5e9c\u770c\u3067\u524d\u9031\u3088\u308a\u6e1b.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.4.12<\/li>\n\n\n\n
                                                                                                          6. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6 1\u533b\u7642\u6a5f\u95a2\u5f53\u305f\u308a\u306e\u60a3\u8005\u6570 \u6d41\u884c\u671f\u306e\u76ee\u5b89\u4e0b\u56de\u308b.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.5.10<\/li>\n\n\n\n
                                                                                                          7. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6 \u201c\u5168\u56fd\u7684\u306a\u6d41\u884c\u671f\u306b\u5165\u3063\u305f\u201d \u539a\u751f\u52b4\u50cd\u7701. NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.11.8<\/li>\n\n\n\n
                                                                                                          8. \u77f3\u7530 \u76f4\uff1a\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6 \u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u3001\u30b3\u30ed\u30ca\u540c\u6642\u611f\u67d3\u306e\u5371\u967a\u6027\u306f\uff1f.\u6559\u80b2\u65b0\u805e.2024.12.5<\/li>\n\n\n\n
                                                                                                          9. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005\u6570 \u524d\u9031\u306e2\u500d\u4ee5\u4e0a 40\u90fd\u9053\u5e9c\u770c\u304c\u201c\u6ce8\u610f\u5831\u201d.NHK\u300c\u30cb\u30e5\u30fc\u30b97\u300d.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8\uff1a2024.12.20<\/li>\n\n\n\n
                                                                                                          10. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6 36\u90fd\u9053\u5e9c\u770c\u3067\u300c\u8b66\u5831\u30ec\u30d9\u30eb\u300d\u8d85\u3048.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2024.12.27<\/li>\n\n\n\n
                                                                                                          11. \u6a4b\u672c \u5fb9\u3001\u6ff5\u5c3e \u4fe1\u53d4\uff1a\u300c\u65b0\u578b\u30b3\u30ed\u30ca5\u985e\u79fb\u884c1\u5e74\u300d.\u897f\u65e5\u672c\u653e\u9001\u682a\u5f0f\u4f1a\u793e\u300cRNC news every.\u300d.2024.5.7<\/li>\n\n\n\n
                                                                                                          12. \u6709\u7530 \u771f\u77e5\u5b50\u3001\u6ff1\u5ddd \u6b63\u5149\uff1a\u5009\u6577\u4e2d\u592e\u75c5\u9662\u306b\u304a\u3051\u308b\u8a3a\u7642\u6a19\u6e96\u5316\u3092\u3081\u3056\u3057\u305f\u9593\u8cea\u6027\u80ba\u708e\u5c02\u9580\u5916\u6765\u306e\u53d6\u308a\u7d44\u307f.\u4e2d\u5916\u88fd\u85ac\u300cmedical forum CHUGAI\u300dVol.28.2024.6<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                            \n
                                                                                                            \n

                                                                                                            2023\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                            \n
                                                                                                              \n
                                                                                                            1. \u77f3\u7530 \u76f4\uff1a\u547c\u5438\u5668\u75be\u60a3\u75be\u60a3\u9023\u8f09\u300c\u5730\u57df\u306e\u547c\u5438\u5668\u75be\u60a3\u3092\u652f\u3048\u308b\u300d\u7b2c1\u56de\u3000COVID-19.\u5c71\u967d\u65b0\u805e.2023.6.5<\/li>\n\n\n\n
                                                                                                            2. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u6d41\u884c\u7d9a\u304f\u3000\u53ce\u675f\u305b\u305a\u6b21\u306e\u30b7\u30fc\u30ba\u30f3\u5165\u308a\u306f99\u5e74\u4ee5\u964d\u521d.\u671d\u65e5\u65b0\u805e\u3000\u533b\u7642\u30b5\u30a4\u30c8\u3000\u671d\u65e5\u65b0\u805e.2023.9.8<\/li>\n\n\n\n
                                                                                                            3. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u306f\u3084\u6d41\u884c\u306e\u5146\u3057.\u5ca9\u624b\u65e5\u5831.2023.9.16<\/li>\n\n\n\n
                                                                                                            4. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005\u6570 \u5897\u52a0\u7d9a\u304f \u201c\u4f8b\u5e74\u3088\u308a\u65e9\u304f\u672c\u683c\u7684\u6d41\u884c\u3082\u201d.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2023.10.13<\/li>\n\n\n\n
                                                                                                            5. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005 1\u533b\u7642\u6a5f\u95a2\u5f53\u305f\u308a11.07\u4eba \u6ce8\u610f\u5831\u57fa\u6e96\u8d85\u3048\u308b.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2023.10.20<\/li>\n\n\n\n
                                                                                                            6. \u77f3\u7530 \u76f4\uff1a\u30b3\u30ed\u30ca\u3001\u30a4\u30f3\u30d5\u30eb\u3044\u305a\u308c\u3082\u611f\u67d3\u6e1b\/\u8aad\u58f2\u65b0\u805e\uff1a2023.11.18<\/li>\n\n\n\n
                                                                                                            7. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u60a3\u8005\u6570 \u4eca\u5b63\u6700\u591a\u306b 1\u533b\u7642\u6a5f\u95a2\u5f53\u305f\u308a21.66\u4eba.NHK\u30cb\u30e5\u30fc\u30b9\u30b5\u30a4\u30c8.2023.11.24<\/li>\n\n\n\n
                                                                                                            8. \u77f3\u7530 \u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3000\u201c\u7570\u4f8b\u305a\u304f\u3081\u201d\u306e\u611f\u67d3\u62e1\u5927\u3000\u85ac\u4e0d\u8db3\u306b\u96c6\u56e3\u514d\u75ab\u306e\u4f4e\u4e0b\u3000\u3069\u3046\u5bfe\u51e6\u3059\u308b\uff1f\u3000NHK\u300c\u304d\u3087\u3046\u306e\u5065\u5eb7\u300d.2023.12.21.\u518d\u653e\u90012023.12.28<\/li>\n\n\n\n
                                                                                                            9. \u4f0a\u85e4 \u660e\u5e83\uff1a\u547c\u5438\u5668\u75be\u60a3\u75be\u60a3\u9023\u8f09\u300c\u5730\u57df\u306e\u547c\u5438\u5668\u75be\u60a3\u3092\u652f\u3048\u308b\u300d\u7b2c2\u56de\u3000\u975e\u7d50\u6838\u6027\u6297\u9178\u83cc\u75c7.\u5c71\u967d\u65b0\u805e.2023.6.19<\/li>\n\n\n\n
                                                                                                            10. \u4f0a\u85e4 \u660e\u5e83\uff1a\u547c\u5438\u5668\u75be\u60a3\u75be\u60a3\u9023\u8f09\u300c\u5730\u57df\u306e\u547c\u5438\u5668\u75be\u60a3\u3092\u652f\u3048\u308b\u300d\u7b2c3\u56de\u3000\u80ba\u708e.\u5c71\u967d\u65b0\u805e.2023.7.3<\/li>\n\n\n\n
                                                                                                            11. \u6a2a\u5c71 \u4fca\u79c0\uff1a\u547c\u5438\u5668\u75be\u60a3\u75be\u60a3\u9023\u8f09\u300c\u5730\u57df\u306e\u547c\u5438\u5668\u75be\u60a3\u3092\u652f\u3048\u308b\u300d\u7b2c6\u56de\u3000\u80ba\u304c\u3093 .\u5c71\u967d\u65b0\u805e.2023.9.18<\/li>\n\n\n\n
                                                                                                            12. \u6ff1\u5ddd \u6b63\u5149\uff1a\u547c\u5438\u5668\u75be\u60a3\u75be\u60a3\u9023\u8f09\u300c\u5730\u57df\u306e\u547c\u5438\u5668\u75be\u60a3\u3092\u652f\u3048\u308b\u300d\u7b2c5\u56de\u3000\u6c17\u7ba1\u652f\u305c\u3093\u305d\u304f.\u5c71\u967d\u65b0\u805e.2023.9.4<\/li>\n\n\n\n
                                                                                                            13. \u7532\u7530 \u62d3\u4e4b\uff1a\u547c\u5438\u5668\u75be\u60a3\u75be\u60a3\u9023\u8f09\u300c\u5730\u57df\u306e\u547c\u5438\u5668\u75be\u60a3\u3092\u652f\u3048\u308b\u300d\u7b2c4\u56de\u3000COPD.\u5c71\u967d\u65b0\u805e.2023.7.17<\/li>\n\n\n\n
                                                                                                            14. \u6a4b\u672c \u5fb9\uff1a\u30b3\u30ed\u30ca\u75c5\u5e8a\u4f7f\u7528\u9ad8\u6b62\u307e\u308a-\u5ca1\u5c71\u770c\u518570\uff05\u524d\u5f8c.\u5c71\u967d\u65b0\u805e.2023.1.11<\/li>\n\n\n\n
                                                                                                            15. \u6a4b\u672c \u5fb9\uff1a\u300c\u9762\u4f1a\u5236\u9650\u300d\u7de9\u548c\u306e\u52d5\u304d.\u5c71\u967d\u65b0\u805e.2023.7.24<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                              \n
                                                                                                              \n

                                                                                                              2022\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                              \n
                                                                                                                \n
                                                                                                              1. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b62\u5b63\u9023\u7d9a\u4f4e\u6c34\u6e96.\u5171\u540c\u901a\u4fe1.2022.2.24<\/li>\n\n\n\n
                                                                                                              2. \u795e\u6238\u5bdb\u53f2\uff1a\u770c\u5185\u30b3\u30ed\u30ca\u60a3\u8005\u767a\u751f\u304b\u30892\u5e74\u300c6\u5ea6\u306e\u300c\u6ce2\u300d\u6551\u547d\u3078\u596e\u95d8\u300d.\u5c71\u967d\u65b0\u805e.2022.3.22<\/li>\n\n\n\n
                                                                                                              3. \u6642\u5ca1\u53f2\u660e\uff1a\u30b3\u30ed\u30ca\u7b2c7\u6ce2\u306e\u533b\u7642\u6a5f\u95a2\u306e\u73fe\u72b6.RNC\u897f\u65e5\u672c\u653e\u9001\u3000\u30cb\u30e5\u30fc\u30b9every.2022.8.26<\/li>\n\n\n\n
                                                                                                              4. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30fb\u30b3\u30ed\u30ca\u540c\u6642\u6d41\u884c\u5099\u3048.\u8aad\u58f2\u65b0\u805e\u5168\u56fd\u7248.2022.9.27<\/li>\n\n\n\n
                                                                                                              5. \u77f3\u7530\u3000\u76f4\uff1a\uff2e\uff28\uff2b\u300c\u304d\u3087\u3046\u306e\u5065\u5eb7\u300d\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068\u65b0\u578b\u30b3\u30ed\u30ca\u3000\u540c\u6642\u6d41\u884c\u306b\u5099\u3048\u308b.NHK.2022.11.3\u653e\u9001.\u6771\u4eac<\/li>\n\n\n\n
                                                                                                              6. \u77f3\u7530\u3000\u76f4\uff1a\u533b\u7642\u30eb\u30cd\u30b5\u30f3\u30b9\u300c\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u300d.\u8aad\u58f2\u65b0\u805e\u5168\u56fd\u7248.2022.11.7<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                                \n
                                                                                                                \n

                                                                                                                2021\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                                \n
                                                                                                                  \n
                                                                                                                1. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u6d41\u884c\u3084\u5bfe\u7b56\u306b\u3064\u3044\u3066.\u671d\u65e5\u65b0\u805e\u79d1\u5b66\u533b\u7642\u90e8.2021.10.8.<\/li>\n\n\n\n
                                                                                                                2. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u6d41\u884c\u3084\u5bfe\u7b56\u306b\u3064\u3044\u3066.\u7523\u7d4c\u65b0\u805e\u6771\u4eac\u672c\u793e.2021.10.19.<\/li>\n\n\n\n
                                                                                                                3. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u6d41\u884c\u3084\u5bfe\u7b56\u306b\u3064\u3044\u3066.\u9031\u9593\u65b0\u6f6e.2021.10.25.<\/li>\n\n\n\n
                                                                                                                4. \u77f3\u7530\u3000\u76f4\uff1a\u30b3\u30ed\u30ca\u306e\u30ef\u30af\u30c1\u30f3\u3068\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u30ef\u30af\u30c1\u30f3\u306e\u95a2\u4fc2.\u65e5\u672c\u30c6\u30ec\u30d3.2021.10.25.<\/li>\n\n\n\n
                                                                                                                5. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068\u30b3\u30ed\u30ca\u306e\u540c\u6642\u6d41\u884c\u306b\u3064\u3044\u3066.\u5c71\u967d\u65b0\u805e.2021.11.10.<\/li>\n\n\n\n
                                                                                                                6. \u77f3\u7530\u3000\u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a3\u30eb\u30b9\u611f\u67d3\u75c7\u306e\u611f\u67d3\u8005\u6570\u306e\u843d\u3061\u7740\u304d\u3068\u3068\u3082\u306b\u6d41\u884c\u518d\u71c3\u304c\u4e88\u60f3\u3055\u308c\u308b\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u8a3a\u7642\u306e\u6700\u524d\u7dda\u306b\u3064\u3044\u3066.Doctorbook.2021.12.21.<\/li>\n\n\n\n
                                                                                                                7. \u6642\u5ca1\u53f2\u660e\uff1a\u30b3\u30ed\u30ca\u767a\u751f1\u5e74\u3092\u632f\u308a\u8fd4\u3063\u3066.\u5c71\u967d\u65b0\u805e.2021.3.10<\/li>\n\n\n\n
                                                                                                                8. \u4f0a\u85e4\u660e\u5e83\uff1a\u897f\u65e5\u672c\u8c6a\u96e8\u306b\u4f34\u3046\u30ec\u30b8\u30aa\u30cd\u30e9\u80ba\u708e\u611f\u67d3\u306b\u3064\u3044\u3066.NHK.2021.6.10.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n\n\n\n
                                                                                                                  \n
                                                                                                                  \n

                                                                                                                  2020\u5e74\u5ea6<\/p>\n<\/span><\/div>\n\n\n\n

                                                                                                                  \n
                                                                                                                    \n
                                                                                                                  1. \u77f3\u7530\u3000\u76f4\uff1a \u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6-COVID-19 \u30a2\u30c9\u30db\u30c3\u30af\u59d4\u54e1\u4f1a\u3067\u306e\u63d0\u8a00\u306b\u3064\u3044\u3066.\u671d\u65e5\u65b0\u805e.2020.8.3.<\/li>\n\n\n\n
                                                                                                                  2. \u77f3\u7530\u3000\u76f4\uff1a\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6-COVID-19 \u30a2\u30c9\u30db\u30c3\u30af\u59d4\u54e1\u4f1a\u3067\u306e\u63d0\u8a00\u306b\u3064\u3044\u3066.\u3058\u307b\u3046.2020.8.5.<\/li>\n\n\n\n
                                                                                                                  3. \u77f3\u7530\u3000\u76f4\uff1a\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6-COVID-19 \u30a2\u30c9\u30db\u30c3\u30af\u59d4\u54e1\u4f1a\u3067\u306e\u63d0\u8a00\u306b\u3064\u3044\u3066.\u8aad\u58f2\u30c6\u30ec\u30d3.2020.8.13.<\/li>\n\n\n\n
                                                                                                                  4. \u77f3\u7530\u3000\u76f4\uff1aCORONA\u3068\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u540c\u6642\u6d41\u884c\u306b\u3064\u3044\u3066. \u8aad\u58f2\u65b0\u805e\u6771\u4eac\u672c\u793e\u533b\u7642\u90e8.2020.8.17.<\/li>\n\n\n\n
                                                                                                                  5. \u77f3\u7530\u3000\u76f4\uff1a\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u4e88\u9632\u30ef\u30af\u30c1\u30f3\u306b\u3064\u3044\u3066. \u671d\u65e5\u65b0\u805e\u6771\u4eac\u672c\u793e\u6587\u5316\u304f\u3089\u3057\u5831\u9053\u90e8.2020.8.18.<\/li>\n\n\n\n
                                                                                                                  6. \u77f3\u7530\u3000\u76f4\uff1a \u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6-COVID-19 \u30a2\u30c9\u30db\u30c3\u30af\u59d4\u54e1\u4f1a\u3067\u306e\u63d0\u8a00\u306b\u3064\u3044\u3066.\u5c71\u967d\u65b0\u805e.2020.8.24.<\/li>\n\n\n\n
                                                                                                                  7. \u77f3\u7530\u3000\u76f4\uff1a\u65b0\u578b\u30b3\u30ed\u30ca\u3068\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u540c\u6642\u6d41\u884c\u306b\u5099\u3048\u305f\u5185\u5bb9\u306b\u3064\u3044\u3066.\u671d\u65e5\u65b0\u805e.2020.8.27.<\/li>\n\n\n\n
                                                                                                                  8. \u77f3\u7530\u3000\u76f4\uff1a \u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6-COVID-19 \u30a2\u30c9\u30db\u30c3\u30af\u59d4\u54e1\u4f1a\u3067\u306e\u63d0\u8a00\u306b\u3064\u3044\u3066.\u6bce\u65e5\u65b0\u805e.20209.2.<\/li>\n\n\n\n
                                                                                                                  9. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u5bfe\u5fdc\u306b\u3064\u3044\u3066. \u671d\u65e5\u65b0\u805e\u51fa\u7248\u300cAERA\u300d.2020.9.8<\/li>\n\n\n\n
                                                                                                                  10. \u77f3\u7530\u3000\u76f4\uff1a\u300c\u611f\u67d3\u75c7\u306b\u95a2\u3059\u308b\u77e5\u8b58\u300d\u3092\u8aad\u8005\u306b\u5c4a\u3051\u3001\u300c\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308b\u8aa4\u89e3\u3084\u77e5\u8b58\u4e0d\u8db3\u300d\u3092\u89e3\u6d88\u3057\u3066\u3082\u3089\u3046\u3001\u3068\u3044\u3046\u4f01\u753b\u30a4\u30f3\u30bf\u30d3\u30e5\u30fc.\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8.2020.9.10.<\/li>\n\n\n\n
                                                                                                                  11. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u3068COVID-19\u306e\u540c\u6642\u6d41\u884c\u306e\u5371\u967a\u6027\u3084\u8a3a\u65ad\u306e\u30dd\u30a4\u30f3\u30c8\u306b\u3064\u3044\u3066. \u30e1\u30c9\u30d4\u30a2\u30c1\u30e3\u30f3\u30cd\u30eb.2020.9.14<\/li>\n\n\n\n
                                                                                                                  12. \u77f3\u7530\u3000\u76f4\uff1a\u300c\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u3068\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30a6\u30a4\u30eb\u30b9\u306e\u540c\u6642\u611f\u67d3\u300d\u3084\u300c\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u306e\u57fa\u790e\u77e5\u8b58\u30fb\u7dca\u6025\u5bfe\u7b56\u300d\u306a\u3069\u306b\u95a2\u3057\u3066. \u5065\u5eb7365.2020.9.29.<\/li>\n\n\n\n
                                                                                                                  13. \u77f3\u7530\u3000\u76f4\uff1a9\/30\u6bce\u65e5\u65b0\u805e\uff08\u5915\u520a\uff09\u5185\u5bb9\u306e\u7d39\u4ecb.\uff23\uff32\uff23\u30c6\u30ec\u30d3.2020.10.1.<\/li>\n\n\n\n
                                                                                                                  14. \u77f3\u7530\u3000\u76f4\uff1a\u4eca\u5e74\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30ef\u30af\u30c1\u30f3\u4e88\u9632\u63a5\u7a2e\u306e\u91cd\u8981\u6027\u306b\u3064\u3044\u3066.\u516c\u660e\u65b0\u805e.2020.10.1.<\/li>\n\n\n\n
                                                                                                                  15. \u77f3\u7530\u3000\u76f4\uff1a\u300c\u307f\u3093\u306a\u306e\u5065\u5eb7\u30e9\u30a4\u30d6\u30e9\u30ea\u30fc\u300d\u306e12\u67081\u65e5\u66f4\u65b0\u5206\u306e\u300c\u4eca\u51ac\u306e\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u5bfe\u7b56\u300d\u306b\u95a2\u3059\u308b\u7279\u96c6\u8a18\u4e8b.\u4fdd\u5065\u540c\u4eba\u793e.2020.10.8.<\/li>\n\n\n\n
                                                                                                                  16. \u77f3\u7530\u3000\u76f4\uff1a\u5598\u606f\u3068COPD\u60a3\u8005\u5411\u3051\u306e\u751f\u6d3b\u60c5\u5831\u8a8c\u300c\u3059\u3053\u3084\u304b\u30e9\u30a4\u30d5\u300d2\u6708\u306b\u767a\u884c\u4e88\u5b9a\u306e\u300c\u5598\u606f\u3001COPD\u3068\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u300d\u306b\u3064\u3044\u3066.\u6bce\u65e5\u65b0\u805e\u51fa\u7248.2020.10.9.<\/li>\n\n\n\n
                                                                                                                  17. \u6709\u7530\u771f\u77e5\u5b50\uff1a\u9032\u884c\u6027\u7dda\u7dad\u5316\u3092\u4f34\u3046\u9593\u8cea\u6027\u80ba\u708e\u3068\u306f\uff1fPF-ILD.\u5c71\u967d\u65b0\u805e.2020.12.25\u63b2\u8f09.<\/li>\n<\/ol>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

                                                                                                                    \u8a3a\u7642\u5b9f\u7e3e 2023\u5e74\u5ea6-2024\u5e74\u5ea6 \u5165\u9662\u60a3\u8005\u6570 \u5358\u4f4d\uff1a\u4eba 2023\u5e74\u5ea6 2024\u5e74\u5ea6 \u5165\u9662\u60a3\u8005\u6570 2076 2114 \u6551\u6025\u5916\u6765\u60a3\u8005\u6570 132 278 \u5165\u9662\u4e2d\u5f80\u8a3a\u60a3\u8005\u6570 522 727 2023\u5e74\u5ea6\u30fc2024\u5e74\u5ea6\u5404\u7a2e\u691c\u67fb […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":10,"menu_order":103,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-625","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/comments?post=625"}],"version-history":[{"count":1,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/625\/revisions"}],"predecessor-version":[{"id":1523,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/625\/revisions\/1523"}],"up":[{"embeddable":true,"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/pages\/10"}],"wp:attachment":[{"href":"https:\/\/www.kchnet.or.jp\/krm\/wp-json\/wp\/v2\/media?parent=625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}